Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended | |
Sep. 30, 2013 | Nov. 08, 2013 | |
Document and Entity Information [Abstract] | ' | ' |
Document Type | '10-Q | ' |
Amendment Flag | 'false | ' |
Document Period End Date | 30-Sep-13 | ' |
Document Fiscal Year Focus | '2013 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Trading Symbol | 'PRIVATE | ' |
Entity Registrant Name | 'ACCELLENT INC | ' |
Entity Central Index Key | '0001342505 | ' |
Current Fiscal Year End Date | '--12-31 | ' |
Entity Filer Category | 'Non-accelerated Filer | ' |
Entity Common Stock, Shares Outstanding | ' | 1,000 |
Unaudited_Condensed_Consolidat
Unaudited Condensed Consolidated Balance Sheets (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash | $64,577 | $59,902 |
Accounts receivable, net of allowances of $2,106 and $2,508 as of December 31, 2012 and September 30, 2013, respectively | 56,735 | 49,403 |
Inventory | 63,329 | 57,069 |
Prepaid expenses and other current assets | 3,403 | 10,973 |
Total current assets | 188,044 | 177,347 |
Property, plant and equipment, net | 116,315 | 114,809 |
Assets held for sale | 880 | 1,060 |
Goodwill | 556,315 | 619,443 |
Other intangible assets, net | 123,543 | 134,747 |
Deferred financing costs and other assets, net | 11,634 | 13,766 |
Total assets | 996,731 | 1,061,172 |
Current liabilities: | ' | ' |
Current portion of long-term debt | 7 | 11 |
Accounts payable | 22,259 | 20,044 |
Accrued payroll and benefits | 11,766 | 6,829 |
Accrued interest | 18,804 | 19,323 |
Accrued expenses and other current liabilities | 15,915 | 17,359 |
Total current liabilities | 68,751 | 63,566 |
Long-term debt | 713,560 | 713,294 |
Other liabilities | 40,984 | 39,905 |
Total liabilities | 823,295 | 816,765 |
Commitments and contingencies (Note 12) | ' | ' |
Stockholders' equity: | ' | ' |
Common stock, par value $0.01 per share, 50,000,000 shares authorized; 1,000 shares issued and outstanding at December 31, 2012 and September 30, 2013, respectively | 0 | 0 |
Additional paid-in capital | 640,503 | 639,610 |
Accumulated other comprehensive loss | -2,041 | -2,554 |
Accumulated deficit | -465,026 | -392,649 |
Total stockholders’ equity | 173,436 | 244,407 |
Total liabilities and stockholders’ equity | $996,731 | $1,061,172 |
Unaudited_Condensed_Consolidat1
Unaudited Condensed Consolidated Balance Sheets (Parenthetical) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, except Share data, unless otherwise specified | ||
Statement of Financial Position [Abstract] | ' | ' |
Accounts receivable, allowances | $2,508 | $2,106 |
Common stock, par value | $0.01 | $0.01 |
Common stock, shares authorized | 50,000,000 | 50,000,000 |
Common stock, shares issued | 1,000 | 1,000 |
Common stock, shares outstanding | 1,000 | 1,000 |
Unaudited_Condensed_Consolidat2
Unaudited Condensed Consolidated Statements of Operations (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Income Statement [Abstract] | ' | ' | ' | ' |
Net sales | $135,437 | $125,961 | $386,968 | $376,526 |
Cost of sales (exclusive of amortization) | 97,561 | 92,250 | 287,819 | 280,370 |
Gross profit | 37,876 | 33,711 | 99,149 | 96,156 |
Operating expenses: | ' | ' | ' | ' |
Selling, general and administrative expenses | 12,511 | 12,833 | 39,536 | 41,502 |
Research and development expenses | 508 | 419 | 1,507 | 1,364 |
Impairment of goodwill | 0 | 0 | 63,128 | 0 |
Restructuring expenses | 66 | 714 | -115 | 2,552 |
(Gain) loss on disposal of assets | 204 | -221 | 896 | -254 |
Amortization of intangible assets | 3,735 | 3,735 | 11,205 | 11,205 |
Total operating expenses | 17,024 | 17,480 | 116,157 | 56,369 |
Income (loss) from continuing operations | 20,852 | 16,231 | -17,008 | 39,787 |
Other (expense) income, net: | ' | ' | ' | ' |
Interest expense, net | -17,288 | -17,379 | -51,865 | -51,879 |
Other income (expense), net | -103 | 592 | -283 | -90 |
Total other expense, net | -17,391 | -16,787 | -52,148 | -51,969 |
(Loss) income from continuing operations before income taxes | 3,461 | -556 | -69,156 | -12,182 |
Provision for income taxes | 1,035 | 999 | 3,158 | 2,717 |
Net (loss) income from continuing operations | 2,426 | -1,555 | -72,314 | -14,899 |
Net loss from discontinued operations, net of tax of $111 and $515 for the three and nine months ended September 30, 2012, respectively, and net of tax of $0 for the three and nine months ended September 30, 2013, respectively | -63 | -4,925 | -63 | -4,175 |
Net (loss) income | $2,363 | ($6,480) | ($72,377) | ($19,074) |
Unaudited_Condensed_Consolidat3
Unaudited Condensed Consolidated Statements of Operations (Paranthetical) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Income tax expense | $1,035 | $999 | $3,158 | $2,717 |
Segment, Discontinued Operations [Member] | ' | ' | ' | ' |
Income tax expense | $0 | $111 | $0 | $515 |
Unaudited_Condensed_Consolidat4
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Statement of Other Comprehensive Income [Abstract] | ' | ' | ' | ' |
Net (loss) income | $2,363 | ($6,480) | ($72,377) | ($19,074) |
Other comprehensive income: | ' | ' | ' | ' |
Unrealized (loss) gain on available for sale security | 0 | -250 | 32 | -57 |
Realized gain on available for sale security | 0 | 0 | -242 | 0 |
Cumulative translation adjustment | 655 | 344 | 723 | 358 |
Other comprehensive income | 655 | 94 | 513 | 301 |
Comprehensive (loss) income | $3,018 | ($6,386) | ($71,864) | ($18,773) |
Unaudited_Condensed_Consolidat5
Unaudited Condensed Consolidated Statements of Cash Flows (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Cash flows from operating activities: | ' | ' |
Net (loss) income | ($72,377) | ($19,074) |
Less net income from discontinued operations, net of tax | -63 | -4,175 |
Net (loss) income from continuing operations | -72,314 | -14,899 |
Adjustments to reconcile net loss to net cash provided by operating activities: | ' | ' |
Depreciation and amortization | 24,634 | 29,578 |
Amortization of debt discounts and non-cash interest accrued | 2,449 | 2,329 |
Restructuring charges, net of payments | 0 | 1,711 |
Impairment of goodwill | 63,128 | 0 |
(Gain) loss on disposal of assets | 896 | -254 |
Realized gain on available for sale of security | -242 | 0 |
Deferred income tax expense | 1,785 | 2,099 |
Non-cash compensation expense | 908 | 432 |
Changes in operating assets and liabilities: | ' | ' |
Accounts receivable | -7,319 | -3,853 |
Inventory | -6,150 | -2,954 |
Prepaid expenses and other current assets | -757 | -824 |
Accounts payable, accrued expenses and other liabilities | 5,599 | 381 |
Net cash provided by operating activities of continuing operations | 12,617 | 13,746 |
Net cash provided by (used in) operating activities of discontinued operations | -265 | 2,406 |
Net cash provided by operating activities | 12,352 | 16,152 |
Cash flows from investing activities: | ' | ' |
Capital expenditures | -16,193 | -13,180 |
Proceeds from sale of property and equipment | 68 | 264 |
Proceeds from the sale of available for sale securities | 242 | 0 |
Net cash used in investing activities of continuing operations | -15,883 | -12,916 |
Net cash provided by investing activities of discontinued operations | 7,987 | 7,484 |
Net cash used in investing activities | -7,896 | -5,432 |
Cash flows from financing activities: | ' | ' |
Repayments of long-term debt and capital lease obligations | -9 | -16 |
Repurchase of common stock | 0 | -43 |
Net cash used in financing activities | -9 | -59 |
Effect of exchange rate changes | 228 | 68 |
Net increase in cash | 4,675 | 10,729 |
Cash, beginning of period | 59,902 | 38,858 |
Cash, end of period | 64,577 | 49,587 |
Supplemental disclosure of cash flow information: | ' | ' |
Cash paid for interest | 49,846 | 50,270 |
Cash paid for income taxes | 1,165 | 2,749 |
Supplemental disclosure of non-cash investing and financing activities: | ' | ' |
Property and equipment purchases included in accrued expenses | $997 | $854 |
Summary_of_significant_account
Summary of significant accounting policies | 9 Months Ended | |||||||||||
Sep. 30, 2013 | ||||||||||||
Accounting Policies [Abstract] | ' | |||||||||||
Summary of significant accounting policies | ' | |||||||||||
Summary of significant accounting policies | ||||||||||||
Basis of Presentation | ||||||||||||
The unaudited condensed consolidated financial statements include the accounts of Accellent Inc. and its wholly owned subsidiaries (collectively, the “Company”). All intercompany transactions have been eliminated. | ||||||||||||
The Company has prepared the accompanying unaudited condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("GAAP") for complete financial statements. The Company has prepared the accompanying unaudited condensed consolidated financial statements on the same basis as the audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2012, and in the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of the interim periods presented. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full fiscal year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed with the SEC on April 1, 2013. | ||||||||||||
During the first quarter of 2013, the Company reorganized its business into two segments. The reorganization changed the reporting structure and changed the composition of the Company's reporting units. During the third quarter of 2013 the Company classified certain long term assets as held for sale (see Note 7). As a result, prior year amounts have been reclassified to conform to the current year’s presentation. | ||||||||||||
Customer Concentration | ||||||||||||
During the three and nine months ended September 30, 2012, the Company's ten largest customers accounted for approximately 62% and 64% of its consolidated net sales. During the three and nine months ended September 30, 2013, the Company's ten largest customers accounted for approximately 66% and 67% of its consolidated net sales, respectively. | ||||||||||||
The actual percentage of net sales derived from each customer whose sales represented 10% or more of the Company's consolidated net sales was as follows for the periods presented: | ||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||
2012 | 2013 | 2012 | 2013 | |||||||||
Customer A | 13 | % | 17 | % | 13 | % | 16 | % | ||||
Customer B | 15 | % | 14 | % | 16 | % | 14 | % | ||||
Customer C | 11 | % | 11 | % | 11 | % | 11 | % | ||||
Customer D | * | * | * | 10 | % | |||||||
(*) Less than 10% | ||||||||||||
At September 30, 2013, Customer A accounted for approximately 19% and Customers B and C each accounted for approximately 10% of accounts receivable, net. At December 31, 2012, Customers A and B each accounted for approximately 13% and 12%, respectively, of accounts receivable, net. |
New_Accounting_Pronouncements
New Accounting Pronouncements | 9 Months Ended |
Sep. 30, 2013 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | ' |
New Accounting Pronouncements | ' |
New Accounting Pronouncements | |
On February 5, 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income." This accounting update requires additional disclosure requirements about reclassification adjustments out of accumulated other comprehensive income ("AOCI"). These adjustments include (1) changes in AOCI balances by component and (2) significant items reclassified out of AOCI. The ASU does not change the current requirements for the reporting of comprehensive income. The Company adopted the provisions of this ASU on January 1, 2013 and the adoption did not have a significant impact on the Company’s consolidated financial position, results of operations or cash flows. | |
On July 18, 2013, the FASB issued ASU No. 2013-11, “Presentation of a Liability for an Unrecognized Tax Benefit When a Net Operating Loss or Tax Credit Carryforward Exists." This accounting update requires that an unrecognized tax benefit should be presented as a reduction of a deferred tax asset for a net operating loss (“NOL”) carryforward or other tax credit carryforward when settlement in this manner is available under applicable tax law. This guidance will be effective for the Company’s interim and annual periods beginning January 1, 2014. The Company does not believe the adoption of this guidance will have a material impact on the Company’s consolidated financial position, results of operations or cash flows. |
Inventories
Inventories | 9 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
Inventory Disclosure [Abstract] | ' | |||||||
Inventories | ' | |||||||
Inventories | ||||||||
Inventories consisted of the following at December 31, 2012 and September 30, 2013 (in thousands): | ||||||||
December 31, | September 30, | |||||||
2012 | 2013 | |||||||
Raw materials | $ | 12,100 | $ | 16,147 | ||||
Work-in-process | 27,779 | 30,409 | ||||||
Finished goods | 17,190 | 16,773 | ||||||
Total | $ | 57,069 | $ | 63,329 | ||||
Goodwill_and_intangible_assets
Goodwill and intangible assets | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |||||||||||||||
Goodwill and intangible assets | ' | |||||||||||||||
Goodwill and intangible assets | ||||||||||||||||
Goodwill is the amount by which the cost of acquired net assets in a business combination exceeds the fair value of net identifiable assets acquired. Intangible assets include the value ascribed to trade names and trademarks, developed technology and know-how, as well as customer contracts and relationships obtained in connection with business combinations. During the first quarter of 2013, the Company reorganized its business into two segments: Advanced Surgical ("AS Segment") and Cardio & Vascular ("CV Segment"). | ||||||||||||||||
The evaluation of the reporting units has also been reassessed and changed to reflect the current structure and operations. During the first quarter of fiscal 2013, goodwill was assigned to the new reporting units based on the relative fair values of the reporting units. This resulted in goodwill of $134 million being assigned to its Advanced Surgical reporting unit, and $485.4 million being assigned to its Cardio & Vascular reporting unit. | ||||||||||||||||
After the preliminary allocation of the goodwill, the carrying amount of the Advanced Surgical reporting unit exceeded its fair value by approximately $16 million, which required the Company to perform an interim goodwill impairment test for the Advanced Surgical reporting unit. Pursuant to the next step of impairment testing, the Company calculated an implied fair value of goodwill based on a hypothetical purchase price allocation. During the first quarter of 2013, the Company had not finalized this step of its impairment testing due to the complexities involved in estimating fair value. In accordance with accounting guidance the Company recognized an estimated impairment charge and recorded a pre-tax goodwill impairment charge of $51.0 million in the first quarter of 2013. The Company finalized the second step of the analysis during the second quarter of 2013 and recorded an additional pre-tax goodwill impairment charge of $12.1 million. The Company has recorded a total pre-tax goodwill impairment charge of $63.1 million in the nine months ended September 30, 2013. | ||||||||||||||||
The Company has elected October 31st as its annual impairment assessment date for goodwill and the indefinite lived intangible assets and performs additional impairment tests if triggering events occur. No impairment charges were recorded for goodwill and the indefinite lived intangible assets during the year ended December 31, 2012. | ||||||||||||||||
The Company reports all amortization expense related to finite lived intangible assets separately within its unaudited condensed consolidated statement of operations. For the three and nine months ended September 30, 2012 and 2013, the Company recorded amortization expense related to intangible assets as follows (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Cost of sales | $ | 497 | $ | 497 | $ | 1,491 | $ | 1,491 | ||||||||
Selling, general and administrative | 3,238 | 3,238 | 9,714 | 9,714 | ||||||||||||
Total | $ | 3,735 | $ | 3,735 | $ | 11,205 | $ | 11,205 | ||||||||
Intangible assets consisted of the following at September 30, 2013 (in thousands): | ||||||||||||||||
Gross | Accumulated | Net | ||||||||||||||
Carrying | Amortization | Carrying | ||||||||||||||
Amount | Amount | |||||||||||||||
Developed technology and know how | $ | 16,991 | $ | (15,665 | ) | $ | 1,326 | |||||||||
Customer contracts and relationships | 197,575 | (104,758 | ) | 92,817 | ||||||||||||
Trade names and trademarks | 29,400 | — | 29,400 | |||||||||||||
Total intangible assets | $ | 243,966 | $ | (120,423 | ) | $ | 123,543 | |||||||||
Intangible assets consisted of the following at December 31, 2012 (in thousands): | ||||||||||||||||
Gross | Accumulated | Net | ||||||||||||||
Carrying | Amortization | Carrying | ||||||||||||||
Amount | Amount | |||||||||||||||
Developed technology and know how | $ | 16,991 | $ | (14,174 | ) | $ | 2,817 | |||||||||
Customer contracts and relationships | 197,575 | (95,045 | ) | 102,530 | ||||||||||||
Trade names and trademarks | 29,400 | — | 29,400 | |||||||||||||
Total intangible assets | $ | 243,966 | $ | (109,219 | ) | $ | 134,747 | |||||||||
Estimated intangible asset amortization expense for the remainder of 2013 is approximately $3.7 million. The estimated annual intangible asset amortization expense approximates $13.8 million in 2014, $13.0 million in each year in 2015, 2016, and 2017, and $37.6 million thereafter. | ||||||||||||||||
At December 31, 2012 and September 30, 2013, the remaining weighted-average amortization periods for the Company’s finite lived intangible assets were as follows (in years): | ||||||||||||||||
Remaining weighted - | ||||||||||||||||
average amortization period | ||||||||||||||||
December 31, | September 30, | |||||||||||||||
2012 | 2013 | |||||||||||||||
Developed technology and know how | 1.4 | 0.7 | ||||||||||||||
Customer contracts and relationships | 7.9 | 7.2 | ||||||||||||||
Total finite lived intangible assets | 7.7 | 7.1 |
Longterm_debt
Long-term debt | 9 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
Debt Disclosure [Abstract] | ' | |||||||
Long-term debt | ' | |||||||
Long-term debt | ||||||||
Long-term debt consisted of the following at December 31, 2012 and September 30, 2013 (in thousands): | ||||||||
December 31, | September 30, | |||||||
2012 | 2013 | |||||||
Senior secured notes maturing on February 1, 2017, interest at 8.375% ("Senior Secured Notes") | $ | 400,000 | $ | 400,000 | ||||
Senior subordinated notes maturing on November 1, 2017, interest at 10.0% ("Senior Subordinated Notes") | 315,000 | 315,000 | ||||||
Capital lease obligations | 20 | 11 | ||||||
Total debt | 715,020 | 715,011 | ||||||
Less—unamortized discount | (1,715 | ) | (1,444 | ) | ||||
Less—current portion | (11 | ) | (7 | ) | ||||
Long term debt, excluding current portion | $ | 713,294 | $ | 713,560 | ||||
The Company maintains an asset backed line of credit (the “ABL Revolver”) that provides for up to $75.0 million of borrowing capacity, subject to borrowing base availability. At September 30, 2013, there were no amounts outstanding under the ABL Revolver and the Company’s aggregate borrowing capacity was $38.6 million, after giving effect to outstanding letters of credit totaling $10.9 million and the amount of ineligible accounts receivable and inventories, as defined in the credit agreement governing the ABL Revolver. |
Restructuring
Restructuring | 9 Months Ended | |||||||||||
Sep. 30, 2013 | ||||||||||||
Restructuring and Related Activities [Abstract] | ' | |||||||||||
Restructuring | ' | |||||||||||
Restructuring | ||||||||||||
During the nine months ended September 30, 2013, the Company undertook no material restructuring actions. | ||||||||||||
In December 2011, the Company's Board of Directors approved a plan of closure with respect to the Company's manufacturing facility in Manchester, England. In April of 2012, the Manchester facility was closed, and substantially all employees were terminated. All affected employees were provided with stay-bonuses as well as one-time termination benefits that were received upon cessation of employment, provided they remained with the Company through the closing date. The total one-time termination benefits totaled approximately $0.6 million and were recorded over each employee’s remaining service period as they were required to stay through their termination date to receive the benefits. During the nine months ended September 30, 2012, the Company recorded $1.4 million of restructuring costs related to the facility's closure that are recorded within “Restructuring expenses” in the accompanying unaudited condensed consolidated statement of operations. During the three and nine months ended September 30, 2013, restructuring costs were negligible. | ||||||||||||
In April 2012, the Company announced a plan to close its manufacturing facility in Englewood, Colorado. The Company completed the facility closure in the first quarter of 2013 upon completion of the transfer of the facility's business to the Company's other facilities. In connection with the closure, the Company provided certain one-time termination benefits to affected employees. These one-time termination benefits were recorded over each employee's remaining service period as employees were required to stay through their termination date to receive the benefits. The Company recorded approximately $0.2 million of restructuring costs related to this facility during the three and nine months ended September 30, 2013. | ||||||||||||
The following table summarizes the amounts recorded related to restructuring activities, which are included in the accompanying unaudited condensed consolidated balance sheet as of September 30, 2012 (in thousands): | ||||||||||||
Employee | Other exit | Total | ||||||||||
costs | costs | |||||||||||
Balance, January 1, 2012 | $ | 340 | $ | — | $ | 340 | ||||||
Restructuring expenses | 1,577 | 975 | 2,552 | |||||||||
Payments | (698 | ) | (143 | ) | (841 | ) | ||||||
Balance, September 30, 2012 | $ | 1,219 | $ | 832 | $ | 2,051 | ||||||
The following table summarizes the amounts recorded related to restructuring activities, which are included in the accompanying unaudited condensed consolidated balance sheet as of September 30, 2013 (in thousands): | ||||||||||||
Employee | Other exit | Total | ||||||||||
costs | costs | |||||||||||
Balance, January 1, 2013 | $ | 1,329 | 790 | $ | 2,119 | |||||||
Restructuring expenses | (100 | ) | (15 | ) | (115 | ) | ||||||
Payments | (1,175 | ) | (119 | ) | (1,294 | ) | ||||||
Balance, September 30, 2013 | $ | 54 | $ | 656 | $ | 710 | ||||||
Divestitures
Divestitures | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Text Block [Abstract] | ' | |||||||||||||||
Divestitures | ' | |||||||||||||||
Divestitures & Assets Held for Sale | ||||||||||||||||
As part of the Company's continuing efforts to better focus its efforts and align with its customers, the Company discontinued certain businesses. The Company has accounted for these businesses as discontinued operations and, accordingly, has presented the results of operations and related cash flows as discontinued operations for all periods presented. | ||||||||||||||||
Summary results of the discontinued operations were as follows (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Sales | $ | 2,501 | $ | — | $ | 13,745 | $ | — | ||||||||
Costs and expenses | 7,315 | 63 | 17,399 | 63 | ||||||||||||
Operating loss from discontinued operations | (4,814 | ) | (63 | ) | (3,654 | ) | (63 | ) | ||||||||
Other expenses, net | — | — | (6 | ) | — | |||||||||||
Loss from discontinued operations before income taxes | (4,814 | ) | (63 | ) | (3,660 | ) | (63 | ) | ||||||||
Provision for income taxes | 111 | — | 515 | — | ||||||||||||
Loss from discontinued operations, net of tax | $ | (4,925 | ) | $ | (63 | ) | $ | (4,175 | ) | $ | (63 | ) | ||||
Assets held for Sale | ||||||||||||||||
The Company is in the process of selling its facility located in Huntsville, Alabama. As of September 30, 2013, the property met the requirements to be classified as held for sale in the condensed consolidated balance sheet, and the sale is considered probable within the next twelve months. The assets had a net book value of approximately $1.1 million and $0.9 million as of December 31, 2012 and September 30, 2013, respectively. Assets measured at fair value on a non-recurring basis in the current period include the assets held for sale, as described in Note 11. |
Stockbased_compensation
Stock-based compensation | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||||
Stock-based compensation | ' | |||||||||||||||
Stock-based compensation | ||||||||||||||||
Employee stock-based compensation | ||||||||||||||||
The Company maintains a 2005 Equity Plan for Key Employees of Accellent Holdings Corp. (the “2005 Equity Plan”), which provides for grants of incentive stock options, nonqualified stock options, restricted stock units and stock appreciation rights. Vesting is determined in the applicable stock option agreement and generally occurs either in equal installments over five years from the date of grant (“Time-Based”), or upon achievement of certain performance targets over a five-year period (“Performance-Based”). Targets underlying the vesting of Performance-Based shares are generally achieved upon the attainment of a specified level of Adjusted EBITDA, as defined in the indenture governing the Company’s senior secured notes, measured each calendar year. The vesting requirements for Performance-Based shares permit a catch-up of vesting should the target not be achieved in a calendar year but achieved in a subsequent calendar year, over the five year vesting period. In addition, in connection with the acquisition of the Company in 2005, the Company exchanged fully vested stock options to acquire common shares of its predecessor entities for 4,901,107 fully vested stock options, or “Roll-Over” options, of Accellent Holdings Corp. which are recorded as a liability until such options are exercised, forfeited, expired or settled. | ||||||||||||||||
The table below summarizes the activity relating to the Roll-Over options during the three months ended September 30, 2012 and 2013: | ||||||||||||||||
Three Months Ended | ||||||||||||||||
30-Sep-12 | 30-Sep-13 | |||||||||||||||
Liability | Roll-Over | Liability | Roll-Over | |||||||||||||
(in thousands) | Shares | (in thousands) | Shares | |||||||||||||
Outstanding | Outstanding | |||||||||||||||
Balance at July 1 | $ | 141 | 80,727 | $ | 141 | 80,727 | ||||||||||
Shares repurchased | — | — | — | — | ||||||||||||
Options exercised | — | — | — | — | ||||||||||||
Options forfeited | — | — | — | — | ||||||||||||
Change in fair value | — | — | — | — | ||||||||||||
Balance at end of period | $ | 141 | 80,727 | $ | 141 | 80,727 | ||||||||||
The table below summarizes the activity relating to the Roll-Over options during the nine months ended September 30, 2012 and 2013: | ||||||||||||||||
Nine Months Ended | ||||||||||||||||
30-Sep-12 | 30-Sep-13 | |||||||||||||||
Liability | Roll-Over | Liability | Roll-Over | |||||||||||||
(in thousands) | Shares | (in thousands) | Shares | |||||||||||||
Outstanding | Outstanding | |||||||||||||||
Balance at January 1 | $ | 355 | 201,817 | $ | 141 | 80,727 | ||||||||||
Shares repurchased | (119 | ) | (67,607 | ) | — | — | ||||||||||
Options exercised | (58 | ) | (33,301 | ) | — | — | ||||||||||
Options forfeited | (35 | ) | (20,182 | ) | — | — | ||||||||||
Change in fair value | (2 | ) | — | — | — | |||||||||||
Balance at end of period | $ | 141 | 80,727 | $ | 141 | 80,727 | ||||||||||
The Company’s stock-based compensation expense is based on the fair value of stock-based awards measured at the grant date that is recognized over the relevant service period and includes any adjustments to the fair value of the Company’s liability related to the Roll-Over options. For stock based awards, the Company estimates the fair value of each award on the date of grant using the Black-Scholes option valuation model. For Roll-Over options, the Company estimates their fair value at each balance sheet date. The Black-Scholes option pricing model incorporates assumptions regarding stock price volatility, the expected life of the option, a risk-free interest rate, dividend yield, and an estimate of the fair value of Accellent Holdings Corp.'s common stock. The fair value of Accellent Holdings Corp.’s common stock is determined by the Board of Directors of Accellent Holdings Corp. utilizing a market based approach. The volatility of Accellent Holdings Corp.’s common stock is estimated utilizing a weighted average stock price volatility of its publicly traded peer companies, adjusted for the Company’s financial performance and the risks associated with the illiquid nature of Accellent Holdings Corp.'s common stock. The expected life of an option is estimated based on past exercise experience. The Company used the following assumptions as of September 30, 2013 to determine the fair value of the Roll-Over options: | ||||||||||||||||
September 30, | ||||||||||||||||
2013 | ||||||||||||||||
Expected term to exercise | 0.50 years | |||||||||||||||
Expected volatility | 24.72 | % | ||||||||||||||
Risk-free rate | 0.33 | % | ||||||||||||||
Dividend yield | — | % | ||||||||||||||
During the three months ended September 30, 2012 and 2013, the Company granted stock options to employees to purchase approximately 2,347,500 and 2,102,500 shares, respectively, of Accellent Holdings Corp.'s common stock. Of the total stock options granted during the three months ended September 30, 2012,1,173,750 were Performance-Based awards. During the three months ended September 30, 2013, the Company issued no Performance-Based awards to employees. Stock options granted during the three months ended September 30, 2012 and 2013 had a weighted average grant date fair value of $0.79 and $0.68 per share, respectively. During the three months ended September 30, 2012 and 2013, 125,000 and 90,500 shares, respectively, were forfeited by employees. | ||||||||||||||||
During the nine months ended September 30, 2012 and 2013, the Company granted stock options to employees to purchase approximately 2,772,500 and 2,367,500 shares, respectively, of Accellent Holdings Corp.'s common stock. Of the total stock options granted during the nine months ended September 30, 2012 and 2013, 1,386,250 and 132,500, respectively, were Performance-Based awards. Stock options granted during the nine months ended September 30, 2012 and 2013 had a weighted average grant date fair value of $0.79 and $0.69 per share, respectively. During the nine months ended September 30, 2012 and 2013, 857,916 and 782,000 shares, respectively, were forfeited by employees. | ||||||||||||||||
The following tables summarize the classification of recorded stock-based compensation in the unaudited condensed consolidated statements of operations and the recorded stock-based compensation by type of award for the three and nine months ended September 30, 2012 and 2013. | ||||||||||||||||
Classification of expense (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Cost of sales | $ | 43 | $ | 158 | $ | 81 | $ | 269 | ||||||||
Selling, general and administrative | 139 | 260 | 283 | 549 | ||||||||||||
Total | $ | 182 | $ | 418 | $ | 364 | $ | 818 | ||||||||
Stock-based compensation related to stock awards by type of award (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Time-based vesting options | $ | 130 | $ | 316 | $ | 314 | $ | 508 | ||||||||
Restricted stock awards | 52 | 102 | 52 | 310 | ||||||||||||
Roll-over options | — | — | (2 | ) | — | |||||||||||
Total expense | $ | 182 | $ | 418 | $ | 364 | $ | 818 | ||||||||
At September 30, 2013, the Company determined that attainment of certain of the targets through 2013 necessary for Performance-Based options to vest is not probable. Accordingly, the Company has not recorded stock-based compensation expense for Performance-Based stock awards during the three and nine months ended September 30, 2013. | ||||||||||||||||
The total unvested Performance-Based shares and their aggregate fair values were 4,923,067 and 4,707,355, and $5.1 million and $4.9 million, at September 30, 2012 and 2013, respectively. The total unvested Time-Based shares and their aggregate fair values were 3,131,850 and 4,243,550, and $3.0 million and $3.4 million, at September 30, 2012 and 2013, respectively. | ||||||||||||||||
During the nine months ended September 30, 2012, the Company granted 837,500 shares of Restricted Stock to employees, of which 160,000 were vested and 60,000 were forfeited at September 30, 2013. The awards vest annually each year over a five year period beginning on the grant date. The aggregate grant date fair value was $2,039,750, or $2.50 per share. During the nine months ended September 30, 2013, the Company granted 50,000 shares of Restricted Stock to employees, none of which were vested at September 30, 2013. The awards vest annually each year over a five year period beginning on the grant date. The aggregate grant date fair value was $125,000, or $2.50 per share. The Company recorded approximately $0.1 million of stock-based compensation expense for the three and nine months ended September 30, 2012 related to restricted stock. The Company recorded approximately $0.1 million and $0.3 million of stock-based compensation expense during the three and nine months ended September 30, 2013 related to restricted stock. | ||||||||||||||||
Non-employee stock-based compensation During the three months ended September 30, 2012 and 2013, the Company recognized approximately $22,500 and $30,000, respectively, of non-employee stock-based compensation related to fees paid to members of the Company’s Board of Directors. These fees are recorded as a liability and recorded in “Other liabilities” in the unaudited condensed consolidated balance sheets. | ||||||||||||||||
During the nine months ended September 30, 2012 and 2013, the Company recognized approximately $67,500 and $90,000, respectively, of non-employee stock-based compensation related to fees paid to members of the Company’s Board of Directors. These fees are recorded as a liability and recorded in “Other liabilities” in the unaudited condensed consolidated balance sheets. |
Income_taxes
Income taxes | 9 Months Ended |
Sep. 30, 2013 | |
Income Tax Disclosure [Abstract] | ' |
Income taxes | ' |
Income taxes | |
The Company provides for deferred income taxes resulting from temporary differences between financial and taxable income as well as current taxes attributable to the states and foreign jurisdictions in which the Company is required to pay income taxes. The Company records valuation allowances to reduce deferred tax assets to the amount that is more likely than not to be realized. The Company has not provided for U.S. income taxes on the undistributed earnings of non-U.S. subsidiaries, as these earnings have been permanently reinvested or would be offset by foreign tax credits or net operating losses. | |
Income tax expense for the three and nine months ended September 30, 2012 was $1.0 million and $2.7 million, respectively, and included $0.7 million and $2.1 million, respectively, of deferred income tax expense for differences in the book and tax treatment of goodwill and $0.3 million and $0.6 million, respectively, in state, foreign, and other taxes. | |
Income tax expense for the three and nine months ended September 30, 2013 was $1.0 million and $3.2 million, respectively, and included $0.7 million and $2.0 million, respectively, related to the book and tax treatment of goodwill and approximately $0.3 million and $1.2 million, respectively, of state, foreign, and other taxes. | |
The Company believes that it is more likely than not that the Company will not recognize the benefits of its domestic federal and state deferred tax assets. As a result, the Company continues to provide a full valuation allowance on those deferred tax assets. The Company’s deferred tax assets are not offset by the tax liabilities related to non-deductible goodwill when determining the need for a valuation allowance. The Company had $29.9 million and $31.9 million of net deferred tax liabilities included in “Other liabilities” in the accompanying unaudited condensed consolidated balance sheets as of December 31, 2012 and September 30, 2013, respectively, relating to goodwill basis differences. | |
The Company is subject to income taxes in the U.S. Federal jurisdiction, and various state and foreign jurisdictions. Tax regulations within each jurisdiction are subject to the interpretation of the related tax law and regulations and require significant judgment to apply. The Company is currently under examination by the State of New York for income tax years ended December 31, 2008 through 2010. The Company is currently under examination by the State of Massachusetts for excise tax year ended December 31, 2011. There are no other current income tax audits. The tax years ended December 31, 2005 through 2011 remain subject to examination by major tax jurisdictions. However, since the Company has net operating loss carryforwards, which may be utilized in future years to offset taxable income, those years may also be subject to review by relevant taxing authorities if utilized, notwithstanding that the statute for assessment may have closed. | |
In September 2013, the U.S. Department of the Treasury and the Internal Revenue Service released final regulations relating to guidance on applying tax rules to amounts paid to acquire, produce or improve tangible personal property as well as rules for materials and supplies. The Company is currently assessing these rules and the impacts to the financial statements, if any. |
Related_party_transactions
Related party transactions | 9 Months Ended |
Sep. 30, 2013 | |
Related Party Transactions [Abstract] | ' |
Related party transactions | ' |
Related party transactions | |
The Company maintains a management services agreement with its principal equity owner, Kohlberg, Kravis, Roberts & Co., (“KKR”) pursuant to which KKR provides certain structuring, consulting and management advisory services. During the three and nine months ended September 30, 2012 and 2013, the Company incurred management fees and related expenses pursuant to this agreement of $0.3 million and $1.0 million, respectively. As of December 31, 2012 and September 30, 2013, the Company owed KKR $0.4 million and $0.3 million for each period, respectively for unpaid management fees which are included in “Accrued expenses and other current liabilities” in the accompanying unaudited condensed consolidated balance sheets. The Company has also historically utilized the services of Capstone Consulting LLC (“Capstone”), an entity affiliated with KKR. No fees or expenses related to Capstone were incurred during the three and nine months ended September 30, 2012 and September 30, 2013. At December 31, 2012 the Company owed Capstone $0.3 million, and had no outstanding payables as of September 30, 2013. | |
In addition to the above, entities affiliated with KKR Asset Management (“KKR-AM”), an affiliate of KKR, owned approximately $14.0 million principal amount of the Company’s Senior Secured Notes and approximately $23.4 million principal amount of the Company’s Senior Subordinated Notes at September 30, 2013. At December 31, 2012, entities affiliated with KKR-AM owned approximately $14.7 million principal amount of the Company’s Senior Secured Notes and approximately $23.4 million principal amount of the Company’s Senior Subordinated Notes. | |
The Company sells products to Biomet, Inc., which is privately owned by a consortium of private equity sponsors, including KKR. Net sales resulting from product shipments to Biomet, Inc. during the three and nine months ended September 30, 2012 totaled $0.1 million and $0.3 million, respectively. Net sales resulting from product shipments to Biomet, Inc. during the three and nine months ended September 30, 2013 were approximately $0.1 million, respectively. At December 31, 2012, accounts receivable from Biomet, Inc. aggregated $0.1 million. At September 30, 2013, accounts receivable from Biomet were negligible. | |
The Company utilizes the services of SunGard Data Systems, Inc. (“SunGard”), a provider of software and information processing solutions, which is privately owned by a consortium of private equity sponsors, including KKR and Bain Capital. The Company maintains an agreement with SunGard to provide information systems hosting services for the Company. The Company incurred approximately $0.2 million and $0.6 million in fees in connection with this agreement for the three and nine month periods ended September 30, 2012 and September 30, 2013, respectively. At December 31, 2012 and September 30, 2013, the Company owed SunGard approximately $0.1 million. |
Fair_value_measurements
Fair value measurements | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||
Fair value measurements | ' | |||||||||||||||
Fair value measurements | ||||||||||||||||
The Company determines fair value utilizing a fair value hierarchy that ranks the quality and reliability of the information used to determine fair value. In general, fair values determined using Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. Fair values determined using Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. | ||||||||||||||||
The Company uses the Black-Scholes option pricing model to value its liability for Roll-Over option awards. A roll-forward of the change in fair value of this financial instrument and information regarding the inputs used in the Black-Scholes model, that are determined by management, that is used to derive the Roll-Over options fair value, is included in Note 8. | ||||||||||||||||
The following tables provide a summary of the financial assets and liabilities recorded at fair value at December 31, 2012 and September 30, 2013 (in thousands): | ||||||||||||||||
Fair Value Measurements at | ||||||||||||||||
December 31, 2012 determined using | ||||||||||||||||
Total Carrying | Quoted Prices in | Significant Other | Significant | |||||||||||||
Value at | Active Markets | Observable | Unobservable | |||||||||||||
December 31, | for Identical | Inputs (Level 2) | Inputs | |||||||||||||
2012 | Assets (Level 1) | (Level 3) | ||||||||||||||
Investment in Available for Sale Security | $ | 210 | $ | 210 | $ | — | $ | — | ||||||||
Liability for Roll-Over options | $ | 141 | $ | — | $ | — | $ | 141 | ||||||||
Fair Value Measurements at | ||||||||||||||||
September 30, 2013 determined using | ||||||||||||||||
Total Carrying | Quoted Prices in | Significant Other | Significant | |||||||||||||
Value at | Active Markets | Observable | Unobservable | |||||||||||||
September 30, | for Identical | Inputs (Level 2) | Inputs | |||||||||||||
2013 | Assets (Level 1) | (Level 3) | ||||||||||||||
Liability for Roll-Over options | $ | 141 | $ | — | $ | — | $ | 141 | ||||||||
For other instruments, the estimated fair value has been determined by the Company using available market information; however, considerable judgment is required in interpreting market data to develop these estimates. The methods and assumptions used to estimate the fair value of each class of financial instruments is as set forth below: | ||||||||||||||||
• | Accounts receivable and accounts payable—The carrying amounts of these items are a reasonable estimate of their fair values at December 31, 2012 and September 30, 2013 based on the short-term nature of these items. | |||||||||||||||
• | Borrowings under the Senior Secured Notes due 2017—Borrowings under the Senior Secured Notes have a fixed rate. The Company intends to carry the Senior Secured Notes until their maturity. At September 30, 2013, the fair value of the Senior Secured Notes, which is Level 2 in the fair value hierarchy, was approximately 104.9%, or $419.6 million, compared to their carrying value of $400 million. | |||||||||||||||
• | Borrowings under the Senior Subordinated Notes due 2017—Borrowings under the Senior Subordinated Notes due 2017 have a fixed rate. The Company intends to carry the Senior Subordinated Notes until their maturity. At September 30, 2013 the fair value of the Senior Subordinated Notes, which is Level 2 in the fair value hierarchy, was approximately 92.4%, or $291.1 million, compared to their carrying value of $315 million. | |||||||||||||||
Nonrecurring Fair Value Measurements | ||||||||||||||||
The Company evaluated the assets held for sale using a market approach related to the divestiture of the building in Huntsville, Alabama, which is classified as a Level 2 input within the fair value hierarchy. As bid and transaction values become apparent during the marketing and divestiture process, the fair values of the assets held for sale was established based on the Company's expectations of a sale price. The carrying value of approximately $1.1 million as of December 31, 2012 was written down to fair value, less costs to sell, resulting in a loss of approximately $0.2 million. The loss was recorded in income (loss) from continuing operations. |
Commitments_and_Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2013 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Contingencies | ' |
Contingencies | |
The Company is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, management does not believe that the outcome of any of these legal matters will have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. | |
Product liability claims or product recalls with respect to the Company’s components or the end-products of the Company’s customers into which the Company’s components are incorporated, could require the Company to pay significant damages or to spend significant time and money in litigation or responding to investigations or requests for information. Expenditures on litigation or damages, to the extent not covered by insurance, and declines in revenue could impair the Company’s earnings and the Company’s financial condition. There is no recall or litigation pending or, to the knowledge of the Company, threatened, that the Company expects to have a material effect on the Company’s consolidated financial position, results of operations or cash flow. |
Environmental_matters
Environmental matters | 9 Months Ended |
Sep. 30, 2013 | |
Environmental Remediation Obligations [Abstract] | ' |
Environmental matters | ' |
Environmental matters | |
The Pennsylvania Department of Environmental Protection (“DEP”) filed a petition for review with the U.S. Court of Appeals for the District of Columbia Circuit challenging recent amendments to the U.S. Environmental Protection Agency (“EPA”) National Air Emissions Standards for hazardous air pollutants from halogenated solvent cleaning operations. These revised standards exempt three industry sectors (aerospace, narrow tube manufacturers and facilities that use continuous web-cleaning and halogenated solvent cleaning machines) from facility emission limits for Trichloroethylene (“TCE”) and other degreaser emissions. The EPA has agreed to reconsider the exemption. The Company’s Collegeville facility meets current EPA control standards for TCE emissions and is exempt from the new lower TCE emission limit since the Company manufactures narrow tubes. As part of efforts to lower TCE emissions, the Company has begun to implement a process that will reduce the Company’s TCE emissions generated by its Collegeville facility. However, this process will not reduce TCE emissions to the levels required should a new standard become law. | |
At each of December 31, 2012 and September 30, 2013, the Company maintained a reserve for environmental liabilities of approximately $1.6 million and $1.4 million. The Company expects to pay $0.1 million during the balance of 2013. |
Supplemental_guarantor_condens
Supplemental guarantor condensed consolidating financial statements | 9 Months Ended | |||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||
Condensed Financial Information of Parent Company Only Disclosure [Abstract] | ' | |||||||||||||||||||
Supplemental guarantor condensed consolidating financial statements | ' | |||||||||||||||||||
Supplemental guarantor condensed consolidating financial statements | ||||||||||||||||||||
All of the Company's domestic subsidiaries (the “Subsidiary Guarantors”) that are 100% owned by the Company, directly or indirectly, guarantee on a joint and several, full and unconditional basis, the obligations of Accellent Inc. under the Senior Secured Notes and the Senior Subordinated Notes (collectively, the "Notes"). Foreign subsidiaries of Accellent Inc. (the “Non-Guarantor Subsidiaries”) have not guaranteed the Notes. | ||||||||||||||||||||
The following tables present the unaudited condensed consolidating statements of operations and the unaudited condensed consolidating statements of comprehensive (loss) income for the three and nine months ended September 30, 2012 and 2013, the unaudited condensed consolidating balance sheets as of December 31, 2012 and September 30, 2013, and the unaudited condensed consolidating statements of cash flows for the nine months ended September 30, 2012 and 2013, of Accellent Inc. (the “Parent”), the Subsidiary Guarantors and the Non-Guarantor Subsidiaries. | ||||||||||||||||||||
Unaudited Condensed Consolidating Statements of Operations — | ||||||||||||||||||||
Three months ended September 30, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net sales | $ | — | $ | 115,587 | $ | 10,939 | $ | (565 | ) | $ | 125,961 | |||||||||
Cost of sales (exclusive of amortization) | — | 85,095 | 7,720 | (565 | ) | 92,250 | ||||||||||||||
Selling, general and administrative expenses | 23 | 11,918 | 892 | — | 12,833 | |||||||||||||||
Research and development expenses | — | 210 | 209 | — | 419 | |||||||||||||||
Restructuring expenses | — | 714 | — | — | 714 | |||||||||||||||
Amortization of intangible assets | 3,735 | — | — | — | 3,735 | |||||||||||||||
(Gain) loss on disposal of assets | — | (223 | ) | 2 | — | (221 | ) | |||||||||||||
(Loss) income from continuing operations | (3,758 | ) | 17,873 | 2,116 | — | 16,231 | ||||||||||||||
Interest (expense) income, net | (17,363 | ) | 656 | (672 | ) | — | (17,379 | ) | ||||||||||||
Other income, net | — | 167 | 425 | — | 592 | |||||||||||||||
Equity in earnings (losses) of affiliates | 19,772 | 1,313 | — | (21,085 | ) | — | ||||||||||||||
(Loss) income from continuing operations before income taxes | (1,349 | ) | 20,009 | 1,869 | (21,085 | ) | (556 | ) | ||||||||||||
Provision for income taxes | — | 443 | 556 | — | 999 | |||||||||||||||
Net (loss) income from continuing operations | (1,349 | ) | 19,566 | 1,313 | (21,085 | ) | (1,555 | ) | ||||||||||||
Net (loss) income from discontinued operations, net of tax | (5,131 | ) | 206 | — | — | (4,925 | ) | |||||||||||||
Net (loss) income | $ | (6,480 | ) | $ | 19,772 | $ | 1,313 | $ | (21,085 | ) | $ | (6,480 | ) | |||||||
Unaudited Condensed Consolidating Statements of Operations — | ||||||||||||||||||||
Three months ended September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net sales | $ | — | $ | 123,983 | $ | 11,864 | $ | (410 | ) | $ | 135,437 | |||||||||
Cost of sales (exclusive of amortization) | — | 89,848 | 8,123 | (410 | ) | 97,561 | ||||||||||||||
Selling, general and administrative expenses | 30 | 11,594 | 887 | — | 12,511 | |||||||||||||||
Research and development expenses | — | 294 | 214 | — | 508 | |||||||||||||||
Impairment of goodwill | — | — | — | — | — | |||||||||||||||
Restructuring expenses | — | 66 | — | — | 66 | |||||||||||||||
Amortization of intangible assets | 3,735 | — | — | — | 3,735 | |||||||||||||||
Loss on disposal of assets | — | 148 | 56 | — | 204 | |||||||||||||||
(Loss) income from continuing operations | (3,765 | ) | 22,033 | 2,584 | — | 20,852 | ||||||||||||||
Interest (expense) income, net | (17,287 | ) | 715 | (716 | ) | — | (17,288 | ) | ||||||||||||
Other income (expense), net | — | 1,160 | (1,263 | ) | — | (103 | ) | |||||||||||||
Equity in earnings of affiliates | 23,415 | 202 | — | (23,617 | ) | — | ||||||||||||||
Income (loss) from continuing operations before income taxes | 2,363 | 24,110 | 605 | (23,617 | ) | 3,461 | ||||||||||||||
Provision for income taxes | — | 632 | 403 | — | 1,035 | |||||||||||||||
Net income (loss) from continuing operations | 2,363 | 23,478 | 202 | (23,617 | ) | 2,426 | ||||||||||||||
Net loss from discontinued operations, net of tax | — | (63 | ) | — | — | (63 | ) | |||||||||||||
Net income (loss) | $ | 2,363 | $ | 23,415 | $ | 202 | $ | (23,617 | ) | $ | 2,363 | |||||||||
Unaudited Condensed Consolidating Statements of Operations — | ||||||||||||||||||||
Nine months ended September 30, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net sales | $ | — | $ | 346,842 | $ | 31,397 | $ | (1,713 | ) | $ | 376,526 | |||||||||
Cost of sales (exclusive of amortization) | — | 260,184 | 21,899 | (1,713 | ) | 280,370 | ||||||||||||||
Selling, general and administrative expenses | 69 | 38,702 | 2,731 | — | 41,502 | |||||||||||||||
Research and development expenses | — | 707 | 657 | — | 1,364 | |||||||||||||||
Restructuring expenses | — | 2,552 | — | — | 2,552 | |||||||||||||||
Amortization of intangible assets | 11,205 | — | — | — | 11,205 | |||||||||||||||
(Gain) loss on disposal of assets | — | (264 | ) | 10 | — | (254 | ) | |||||||||||||
(Loss) income from continuing operations | (11,274 | ) | 44,961 | 6,100 | — | 39,787 | ||||||||||||||
Interest (expense) income, net | (51,812 | ) | 1,997 | (2,064 | ) | — | (51,879 | ) | ||||||||||||
Other (expense) income, net | — | (1,154 | ) | 1,064 | — | (90 | ) | |||||||||||||
Equity in earnings of affiliates | 49,143 | 3,273 | — | (52,416 | ) | — | ||||||||||||||
(Loss) income from continuing operations before income taxes | (13,943 | ) | 49,077 | 5,100 | (52,416 | ) | (12,182 | ) | ||||||||||||
Provision for income taxes | — | 890 | 1,827 | — | 2,717 | |||||||||||||||
Net (loss) income from continuing operations | (13,943 | ) | 48,187 | 3,273 | (52,416 | ) | (14,899 | ) | ||||||||||||
Net (loss) income from discontinued operations, net of tax | (5,131 | ) | 956 | — | — | (4,175 | ) | |||||||||||||
Net (loss) income | $ | (19,074 | ) | $ | 49,143 | $ | 3,273 | $ | (52,416 | ) | $ | (19,074 | ) | |||||||
Unaudited Condensed Consolidating Statements of Operations — | ||||||||||||||||||||
Nine months ended September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net sales | $ | — | $ | 355,194 | $ | 32,827 | $ | (1,053 | ) | $ | 386,968 | |||||||||
Cost of sales (exclusive of amortization) | — | 265,785 | 23,087 | (1,053 | ) | 287,819 | ||||||||||||||
Selling, general and administrative expenses | 92 | 36,746 | 2,698 | — | 39,536 | |||||||||||||||
Research and development expenses | — | 919 | 588 | — | 1,507 | |||||||||||||||
Impairment of goodwill | 63,128 | — | — | — | 63,128 | |||||||||||||||
Restructuring expenses | — | (115 | ) | — | — | (115 | ) | |||||||||||||
Amortization of intangible assets | 11,205 | — | — | — | 11,205 | |||||||||||||||
Loss on disposal of assets | — | 814 | 82 | — | 896 | |||||||||||||||
(Loss) income from continuing operations | (74,425 | ) | 51,045 | 6,372 | — | (17,008 | ) | |||||||||||||
Interest (expense) income, net | (51,867 | ) | 2,123 | (2,121 | ) | — | (51,865 | ) | ||||||||||||
Other income (expense), net | 923 | 306 | (1,512 | ) | — | (283 | ) | |||||||||||||
Equity in earnings of affiliates | 52,992 | 1,649 | — | (54,641 | ) | — | ||||||||||||||
(Loss) income from continuing operations before income taxes | (72,377 | ) | 55,123 | 2,739 | (54,641 | ) | (69,156 | ) | ||||||||||||
Provision for income taxes | — | 2,068 | 1,090 | — | 3,158 | |||||||||||||||
Net (loss) income from continuing operations | (72,377 | ) | 53,055 | 1,649 | (54,641 | ) | (72,314 | ) | ||||||||||||
Net loss from discontinued operations, net of tax | — | (63 | ) | — | — | (63 | ) | |||||||||||||
Net (loss) income | $ | (72,377 | ) | $ | 52,992 | $ | 1,649 | $ | (54,641 | ) | $ | (72,377 | ) | |||||||
Unaudited Condensed Consolidating Balance Sheets | ||||||||||||||||||||
December 31, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Cash | $ | — | $ | 53,812 | $ | 6,090 | $ | — | $ | 59,902 | ||||||||||
Accounts receivable, net | — | 46,992 | 2,929 | (518 | ) | 49,403 | ||||||||||||||
Inventories | — | 52,807 | 4,262 | — | 57,069 | |||||||||||||||
Prepaid expenses and other current assets | 215 | 10,399 | 359 | — | 10,973 | |||||||||||||||
Total current assets | 215 | 164,010 | 13,640 | (518 | ) | 177,347 | ||||||||||||||
Property, plant and equipment, net | — | 89,413 | 25,396 | — | 114,809 | |||||||||||||||
Assets held for sale | — | 1,060 | — | — | 1,060 | |||||||||||||||
Intercompany receivables, net | — | 365,713 | — | (365,713 | ) | — | ||||||||||||||
Investment in subsidiaries | 554,794 | 9,143 | — | (563,937 | ) | — | ||||||||||||||
Goodwill | 619,443 | — | — | — | 619,443 | |||||||||||||||
Other intangible assets, net | 134,747 | — | — | — | 134,747 | |||||||||||||||
Deferred financing costs and other assets, net | 13,269 | (8 | ) | 505 | — | 13,766 | ||||||||||||||
Total assets | $ | 1,322,468 | $ | 629,331 | $ | 39,541 | $ | (930,168 | ) | $ | 1,061,172 | |||||||||
Current portion of long-term debt | $ | — | $ | 11 | $ | — | $ | — | $ | 11 | ||||||||||
Accounts payable | 1 | 18,613 | 1,948 | (518 | ) | 20,044 | ||||||||||||||
Accrued expenses and other current liabilities | 19,317 | 20,267 | 3,927 | — | 43,511 | |||||||||||||||
Total current liabilities | 19,318 | 38,891 | 5,875 | (518 | ) | 63,566 | ||||||||||||||
Long-term debt | 1,057,832 | — | 21,175 | (365,713 | ) | 713,294 | ||||||||||||||
Other long-term liabilities | 911 | 35,646 | 3,348 | — | 39,905 | |||||||||||||||
Total liabilities | 1,078,061 | 74,537 | 30,398 | (366,231 | ) | 816,765 | ||||||||||||||
Equity | 244,407 | 554,794 | 9,143 | (563,937 | ) | 244,407 | ||||||||||||||
Total liabilities and equity | $ | 1,322,468 | $ | 629,331 | $ | 39,541 | $ | (930,168 | ) | $ | 1,061,172 | |||||||||
Unaudited Condensed Consolidating Balance Sheets | ||||||||||||||||||||
September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Cash | $ | — | $ | 56,651 | $ | 7,926 | $ | — | $ | 64,577 | ||||||||||
Accounts receivable, net | — | 52,603 | 4,559 | (427 | ) | 56,735 | ||||||||||||||
Inventories | — | 58,232 | 5,097 | — | 63,329 | |||||||||||||||
Prepaid expenses and other current assets | 24 | 3,095 | 284 | — | 3,403 | |||||||||||||||
Total current assets | 24 | 170,581 | 17,866 | (427 | ) | 188,044 | ||||||||||||||
Property, plant and equipment, net | — | 87,721 | 28,594 | — | 116,315 | |||||||||||||||
Assets held for sale | — | 880 | — | — | 880 | |||||||||||||||
Intercompany receivables, net | — | 417,205 | — | (417,205 | ) | — | ||||||||||||||
Investment in subsidiaries | 608,507 | 11,523 | — | (620,030 | ) | — | ||||||||||||||
Goodwill | 556,315 | — | — | — | 556,315 | |||||||||||||||
Other intangible assets, net | 123,543 | — | — | — | 123,543 | |||||||||||||||
Deferred financing costs and other assets, net | 11,090 | 64 | 480 | — | 11,634 | |||||||||||||||
Total assets | $ | 1,299,479 | $ | 687,974 | $ | 46,940 | $ | (1,037,662 | ) | $ | 996,731 | |||||||||
Current portion of long-term debt | $ | — | $ | 7 | $ | — | $ | — | $ | 7 | ||||||||||
Accounts payable | — | 20,845 | 1,841 | (427 | ) | 22,259 | ||||||||||||||
Accrued expenses and other current liabilities | 18,804 | 22,098 | 5,583 | — | 46,485 | |||||||||||||||
Total current liabilities | 18,804 | 42,950 | 7,424 | (427 | ) | 68,751 | ||||||||||||||
Long-term debt | 1,106,313 | — | 24,452 | (417,205 | ) | 713,560 | ||||||||||||||
Other long-term liabilities | 926 | 36,517 | 3,541 | — | 40,984 | |||||||||||||||
Total liabilities | 1,126,043 | 79,467 | 35,417 | (417,632 | ) | 823,295 | ||||||||||||||
Equity | 173,436 | 608,507 | 11,523 | (620,030 | ) | 173,436 | ||||||||||||||
Total liabilities and equity | $ | 1,299,479 | $ | 687,974 | $ | 46,940 | $ | (1,037,662 | ) | $ | 996,731 | |||||||||
Unaudited Condensed Consolidating Statements of Comprehensive (Loss) Income | ||||||||||||||||||||
Three months ended September 30, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net (loss) income | $ | (6,480 | ) | $ | 19,772 | $ | 1,313 | $ | (21,085 | ) | $ | (6,480 | ) | |||||||
Other comprehensive income (loss): | ||||||||||||||||||||
Unrealized gain on available for sale security | (250 | ) | — | — | — | (250 | ) | |||||||||||||
Cumulative translation adjustment | 344 | 163 | 181 | (344 | ) | 344 | ||||||||||||||
Comprehensive (loss) income | $ | (6,386 | ) | $ | 19,935 | $ | 1,494 | $ | (21,429 | ) | $ | (6,386 | ) | |||||||
Unaudited Condensed Consolidating Statements of Comprehensive (Loss) Income | ||||||||||||||||||||
Three months ended September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net income | $ | 2,363 | $ | 23,415 | $ | 202 | $ | (23,617 | ) | $ | 2,363 | |||||||||
Other comprehensive income (loss): | ||||||||||||||||||||
Cumulative translation adjustment | 655 | 269 | 386 | (655 | ) | 655 | ||||||||||||||
Comprehensive income | $ | 3,018 | $ | 23,684 | $ | 588 | $ | (24,272 | ) | $ | 3,018 | |||||||||
Unaudited Condensed Consolidating Statements of Comprehensive (Loss) Income | ||||||||||||||||||||
Nine months ended September 30, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net (loss) income | $ | (19,074 | ) | $ | 49,143 | $ | 3,273 | $ | (52,416 | ) | $ | (19,074 | ) | |||||||
Other comprehensive income (loss): | ||||||||||||||||||||
Unrealized gain on available for sale security | (57 | ) | — | — | — | (57 | ) | |||||||||||||
Cumulative translation adjustment | 358 | 218 | 140 | (358 | ) | 358 | ||||||||||||||
Comprehensive (loss) income | $ | (18,773 | ) | $ | 49,361 | $ | 3,413 | $ | (52,774 | ) | $ | (18,773 | ) | |||||||
Unaudited Condensed Consolidating Statements of Comprehensive (Loss) Income | ||||||||||||||||||||
Nine months ended September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net (loss) income | $ | (72,377 | ) | $ | 52,992 | $ | 1,649 | $ | (54,641 | ) | $ | (72,377 | ) | |||||||
Other comprehensive income (loss): | ||||||||||||||||||||
Unrealized gain on available for sale security | 32 | — | — | — | 32 | |||||||||||||||
Realized gain on available for sale security | (242 | ) | — | — | — | (242 | ) | |||||||||||||
Cumulative translation adjustment | 723 | (8 | ) | 731 | (723 | ) | 723 | |||||||||||||
Comprehensive (loss) income | $ | (71,864 | ) | $ | 52,984 | $ | 2,380 | $ | (55,364 | ) | $ | (71,864 | ) | |||||||
Unaudited Condensed Consolidating Statements of Cash Flows — | ||||||||||||||||||||
Nine months ended September 30, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net cash (used in) provided by operating activities of continuing operations | $ | (49,930 | ) | $ | 59,628 | $ | 4,048 | $ | — | $ | 13,746 | |||||||||
Net cash provided by operating activities of discontinued operations | — | 2,406 | — | — | 2,406 | |||||||||||||||
Net cash (used in) provided by operating activities | (49,930 | ) | 62,034 | 4,048 | — | 16,152 | ||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||||
Capital expenditures | — | (4,552 | ) | (8,628 | ) | — | (13,180 | ) | ||||||||||||
Proceeds from disposition of assets | — | 264 | — | — | 264 | |||||||||||||||
Net cash used in investing activities of continuing operations | — | (4,288 | ) | (8,628 | ) | — | (12,916 | ) | ||||||||||||
Net cash provided by investing activities of discontinued operations | — | 7,484 | — | — | 7,484 | |||||||||||||||
Net cash provided by (used in) investing activities | — | 3,196 | (8,628 | ) | — | (5,432 | ) | |||||||||||||
Cash flows from financing activities: | ||||||||||||||||||||
Repayments of long-term debt and capital lease obligations | — | (14 | ) | (2 | ) | — | (16 | ) | ||||||||||||
Intercompany receipts (advances) | 49,973 | (53,379 | ) | 3,406 | — | — | ||||||||||||||
Repurchase of parent company stock | (43 | ) | — | — | — | (43 | ) | |||||||||||||
Cash flows provided by (used in) financing activities | 49,930 | (53,393 | ) | 3,404 | — | (59 | ) | |||||||||||||
Effect of exchange rate changes in cash | — | 86 | (18 | ) | — | 68 | ||||||||||||||
Net increase (decrease) in cash | — | 11,923 | (1,194 | ) | — | 10,729 | ||||||||||||||
Cash, beginning of period | — | 32,627 | 6,231 | — | 38,858 | |||||||||||||||
Cash, end of period | $ | — | $ | 44,550 | $ | 5,037 | $ | — | $ | 49,587 | ||||||||||
Unaudited Condensed Consolidating Statements of Cash Flows — | ||||||||||||||||||||
Nine months ended September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net cash (used in) provided by operating activities of continuing operations | $ | (48,325 | ) | $ | 56,307 | $ | 4,635 | $ | — | $ | 12,617 | |||||||||
Net cash used in operating activities of discontinued operations | — | (265 | ) | — | — | (265 | ) | |||||||||||||
Net cash (used in) provided by operating activities | (48,325 | ) | 56,042 | 4,635 | — | 12,352 | ||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||||
Capital expenditures | — | (9,877 | ) | (6,316 | ) | — | (16,193 | ) | ||||||||||||
Proceeds from sale of equipment | — | 61 | 7 | — | 68 | |||||||||||||||
Proceeds from the sale of available for sale securities | 242 | — | — | — | 242 | |||||||||||||||
Net cash provided by (used in) investing activities of continuing operations | 242 | (9,816 | ) | (6,309 | ) | — | (15,883 | ) | ||||||||||||
Net cash provided by investing activities of discontinued operations | — | 7,987 | — | — | 7,987 | |||||||||||||||
Net cash provided by (used in) investing activities | 242 | (1,829 | ) | (6,309 | ) | — | (7,896 | ) | ||||||||||||
Cash flows from financing activities: | ||||||||||||||||||||
Repayments of long-term debt and capital lease obligations | — | (9 | ) | — | — | (9 | ) | |||||||||||||
Intercompany receipts (advances) | 48,083 | (51,357 | ) | 3,274 | — | — | ||||||||||||||
Cash flows provided by (used in) financing activities | 48,083 | (51,366 | ) | 3,274 | — | (9 | ) | |||||||||||||
Effect of exchange rate changes in cash | — | (8 | ) | 236 | — | 228 | ||||||||||||||
Net increase in cash | — | 2,839 | 1,836 | — | 4,675 | |||||||||||||||
Cash, beginning of period | — | 53,812 | 6,090 | — | 59,902 | |||||||||||||||
Cash, end of period | $ | — | $ | 56,651 | $ | 7,926 | $ | — | $ | 64,577 | ||||||||||
Changes_in_Stockholders_Equity
Changes in Stockholders' Equity | 9 Months Ended | ||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | ' | ||||||||||||||||||||||
Changes in Stockholders' Equity | ' | ||||||||||||||||||||||
Changes in Stockholders' Equity | |||||||||||||||||||||||
The following table summarizes the changes in stockholders’ equity during the nine months ended September 30, 2013 (in thousands except share data): | |||||||||||||||||||||||
Common Stock | Additional | Accumulated | Accumulated | Total | |||||||||||||||||||
Paid-In | other | (deficit) | Equity | ||||||||||||||||||||
Capital | comprehensive | ||||||||||||||||||||||
Shares | Amount | income (loss) | |||||||||||||||||||||
Balance, January 1, 2013 | 1,000 | $ | — | $ | 639,610 | $ | (2,554 | ) | $ | (392,649 | ) | $ | 244,407 | ||||||||||
Comprehensive loss: | |||||||||||||||||||||||
Net loss | — | — | — | (72,377 | ) | (72,377 | ) | ||||||||||||||||
Unrealized gain on available for sale security | — | — | 32 | — | 32 | ||||||||||||||||||
Realized gain on available for sale security | — | — | (242 | ) | — | (242 | ) | ||||||||||||||||
Cumulative translation adjustment | — | — | 723 | — | 723 | ||||||||||||||||||
Total comprehensive loss | (71,864 | ) | |||||||||||||||||||||
Stock-based compensation and other | — | 893 | — | — | 893 | ||||||||||||||||||
Balance, September 30, 2013 | 1,000 | $ | — | $ | 640,503 | $ | (2,041 | ) | $ | (465,026 | ) | $ | 173,436 | ||||||||||
Changes_in_Accumulated_Other_C
Changes in Accumulated Other Comprehensive Loss | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Equity [Abstract] | ' | |||||||||||||||
Changes in Accumulated Other Comprehensive Loss | ' | |||||||||||||||
Changes in Accumulated Other Comprehensive Loss | ||||||||||||||||
The following table summarizes the changes in accumulated other comprehensive (loss) income for the three months ended September 30, 2012 (in thousands): | ||||||||||||||||
Defined Benefit Pension Items | Unrealized Gains and Losses on Available-for-Sale Securities | Foreign Currency Items | Total | |||||||||||||
Balance at July 1, 2012 | $ | (317 | ) | $ | 1,348 | $ | (2,090 | ) | $ | (1,059 | ) | |||||
Other comprehensive (loss) income before reclassifications | — | (250 | ) | 344 | 94 | |||||||||||
Amounts reclassified from accumulated other comprehensive income | — | — | — | — | ||||||||||||
Net current-period other comprehensive (loss) income | — | (250 | ) | 344 | 94 | |||||||||||
Balance at September 30, 2012 | $ | (317 | ) | $ | 1,098 | $ | (1,746 | ) | $ | (965 | ) | |||||
The following table summarizes the changes in accumulated other comprehensive income (loss) for the three months ended September 30, 2013 (in thousands): | ||||||||||||||||
Defined Benefit Pension Items | Unrealized Gains and Losses on Available-for-Sale Securities | Foreign Currency Items | Total | |||||||||||||
Balance at July 1, 2013 | $ | (1,159 | ) | $ | — | $ | (1,537 | ) | $ | (2,696 | ) | |||||
Other comprehensive income before reclassifications | — | — | 655 | 655 | ||||||||||||
Amounts reclassified from accumulated other comprehensive income | — | — | — | — | ||||||||||||
Net current-period other comprehensive income | — | — | 655 | 655 | ||||||||||||
Balance at September 30, 2013 | $ | (1,159 | ) | $ | — | $ | (882 | ) | $ | (2,041 | ) | |||||
The following table summarizes the changes in accumulated other comprehensive (loss) income for the nine months ended September 30, 2012 (in thousands): | ||||||||||||||||
Defined Benefit Pension Items | Unrealized Gains and Losses on Available-for-Sale Securities | Foreign Currency Items | Total | |||||||||||||
Balance at January 1, 2012 | $ | (317 | ) | $ | 1,155 | $ | (2,104 | ) | $ | (1,266 | ) | |||||
Other comprehensive (loss) income before reclassifications | — | (57 | ) | 358 | 301 | |||||||||||
Amounts reclassified from accumulated other comprehensive income | — | — | — | — | ||||||||||||
Net current-period other comprehensive (loss) income | — | (57 | ) | 358 | 301 | |||||||||||
Balance at September 30, 2012 | $ | (317 | ) | $ | 1,098 | $ | (1,746 | ) | $ | (965 | ) | |||||
The following table summarizes the changes in accumulated other comprehensive (loss) income for the nine months ended September 30, 2013 (in thousands): | ||||||||||||||||
Defined Benefit Pension Items | Unrealized Gains and Losses on Available-for-Sale Securities | Foreign Currency Items | Total | |||||||||||||
Balance at January 1, 2013 | $ | (1,159 | ) | $ | 210 | $ | (1,605 | ) | $ | (2,554 | ) | |||||
Other comprehensive (loss) income before reclassifications | — | (210 | ) | 723 | 513 | |||||||||||
Amounts reclassified from accumulated other comprehensive income | — | — | — | — | ||||||||||||
Net current-period other comprehensive (loss) income | — | (210 | ) | 723 | 513 | |||||||||||
Balance at September 30, 2013 | $ | (1,159 | ) | $ | — | $ | (882 | ) | $ | (2,041 | ) | |||||
Segment_Information
Segment Information | 3 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||
Segment and geographical information | ' | |||||||||||||||
Segment Information | ||||||||||||||||
Operating segments, as defined under GAAP, are components of an enterprise that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker in deciding how to allocate resources and assess performance. From 2007 to 2012, the Company has operated centrally with separate and distinct functional leaders for operations, sales, engineering, quality and technology along with information systems, finance and human resources. Through December 31, 2012, the Company operated its facilities under common management reporting on a functional basis to various functional leaders with the Company's Chief Executive Officer with the role chief operating decision maker. | ||||||||||||||||
During the first quarter of 2013, the Company reorganized its business into two segments: Advanced Surgical ("AS" or "AS Segment") and Cardio & Vascular ("CV" or "CV Segment"). The AS Segment is led by the president of AS who reports to the Chief Executive Officer. This segment produces products for (1) orthopaedics that include joint, spinal, arthroscopy, and trauma products, and (2) endoscopy that include gastrointestinal, urology, and laparoscopy products. The CV Segment is also led by the president of CV who reports to the Chief Executive Officer. This segment produces products for (1) cardiac rhythm management that includes pacemakers, implantable defribillators, tools and accessories, (2) cardiovascular that includes cardiac and peripheral stents, guide wires, catheters and delivery systems, and (3) cardiac surgery that includes heart valves, perfusion cannulae kits, vein grafting and bypass instruments. As a result, the Company's reportable segment information has been restated to reflect the current structure. | ||||||||||||||||
The Company allocates resources based on revenues as well as earnings before interest, taxes, depreciation, amortization, and other specific and non-recurring items ("Adjusted EBITDA") of each segment. Those expenses not allocable to each segment include non-allocable overhead costs, selling, general and administrative expenses, including human resources, legal, finance, information technology, general and administrative expenses. Non-allocable expenses also include the amortization of intangible assets and certain restructuring expenses. Corporate services assets include intangible assets, deferred tax assets and liabilities, cash and cash equivalents, debt and other non-allocated assets. | ||||||||||||||||
The Company's net sales and Adjusted EBITDA by segment as well as a reconciliation of Total Adjusted EBITDA to the consolidated loss from continuing operations before provision for income taxes is as follows (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Net sales: | ||||||||||||||||
Cardio & Vascular | $ | 79,550 | $ | 83,337 | $ | 236,235 | $ | 240,505 | ||||||||
Advanced Surgical | 48,996 | 53,169 | 147,170 | 148,827 | ||||||||||||
Intersegment | (2,585 | ) | (1,069 | ) | (6,879 | ) | (2,364 | ) | ||||||||
Total net sales | $ | 125,961 | $ | 135,437 | $ | 376,526 | $ | 386,968 | ||||||||
Adjusted EBITDA: | ||||||||||||||||
Cardio & Vascular | $ | 25,307 | $ | 26,852 | $ | 72,758 | $ | 72,568 | ||||||||
Advanced Surgical | 8,470 | 9,493 | 22,586 | 22,638 | ||||||||||||
Corporate Services | (5,625 | ) | (5,761 | ) | (19,400 | ) | (18,569 | ) | ||||||||
Total Adjusted EBITDA | $ | 28,152 | $ | 30,584 | $ | 75,944 | $ | 76,637 | ||||||||
Reconciliation of Adjusted EBITDA to income (loss) from continuing operations before provision for income taxes | ||||||||||||||||
Impairment of goodwill | $ | — | $ | — | $ | — | $ | (63,128 | ) | |||||||
Interest expense, net | (17,379 | ) | (17,288 | ) | (51,879 | ) | (51,865 | ) | ||||||||
Depreciation and amortization | (10,090 | ) | (8,406 | ) | (29,578 | ) | (24,634 | ) | ||||||||
Stock-based compensation - employees | (182 | ) | (418 | ) | (364 | ) | (818 | ) | ||||||||
Stock-based compensation - non-employees | (23 | ) | (30 | ) | (68 | ) | (90 | ) | ||||||||
Employee severance and relocation | (500 | ) | (152 | ) | (1,870 | ) | (971 | ) | ||||||||
Restructuring expenses | (714 | ) | (66 | ) | (2,552 | ) | 115 | |||||||||
Plant closure costs & other | (194 | ) | (27 | ) | (517 | ) | (1,244 | ) | ||||||||
Currency gain (loss) | 568 | (111 | ) | (152 | ) | (1,231 | ) | |||||||||
Gain (loss) on disposal of property and equipment | 221 | (204 | ) | 254 | (896 | ) | ||||||||||
Other taxes | (80 | ) | (70 | ) | (395 | ) | (218 | ) | ||||||||
Management fees to stockholder | (335 | ) | (351 | ) | (1,005 | ) | (1,055 | ) | ||||||||
Realized gain on available for sale security | — | — | — | 242 | ||||||||||||
Total adjustments | $ | (28,708 | ) | $ | (27,123 | ) | $ | (88,126 | ) | $ | (145,793 | ) | ||||
Income (loss) from continuing operations before provision for income taxes | $ | (556 | ) | $ | 3,461 | $ | (12,182 | ) | $ | (69,156 | ) | |||||
The Company's capital expenditures by segment at September 30, 2012 and September 30, 2013 are as follows (in thousands): | ||||||||||||||||
Nine Months Ended | ||||||||||||||||
September 30, | September 30, | |||||||||||||||
2012 | 2013 | |||||||||||||||
Capital expenditures: | ||||||||||||||||
Cardio & Vascular | $ | 6,191 | $ | 8,144 | ||||||||||||
Advanced Surgical | 6,279 | 7,769 | ||||||||||||||
Corporate | 710 | 280 | ||||||||||||||
Total capital expenditures | $ | 13,180 | $ | 16,193 | ||||||||||||
The Company's assets by segment at December 31, 2012 and September 30, 2013 are as follows (in thousands): | ||||||||||||||||
December 31, | September 30, | |||||||||||||||
2012 | 2013 | |||||||||||||||
Assets: | ||||||||||||||||
Cardio & Vascular | $ | 606,304 | $ | 619,541 | ||||||||||||
Advanced Surgical | 245,619 | 181,577 | ||||||||||||||
Corporate Services | 209,249 | 195,613 | ||||||||||||||
Total assets | $ | 1,061,172 | $ | 996,731 | ||||||||||||
Subsequent_Events
Subsequent Events | 9 Months Ended |
Sep. 30, 2013 | |
Subsequent Events [Abstract] | ' |
Subsequent Events | ' |
Subsequent Events | |
The Company has evaluated the period from September 30, 2013, the date of the unaudited condensed consolidated financial statements, through the date of the issuance and filing of the unaudited consolidated financial statements, and has determined that no material subsequent events have occurred that would affect the information presented in these unaudited condensed consolidated financial statements or require additional disclosure. |
Recovered_Sheet1
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2013 | |
Accounting Policies [Abstract] | ' |
Basis of Presentation | ' |
Basis of Presentation | |
The unaudited condensed consolidated financial statements include the accounts of Accellent Inc. and its wholly owned subsidiaries (collectively, the “Company”). All intercompany transactions have been eliminated. | |
The Company has prepared the accompanying unaudited condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("GAAP") for complete financial statements. The Company has prepared the accompanying unaudited condensed consolidated financial statements on the same basis as the audited financial statements included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2012, and in the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of the interim periods presented. The operating results for the interim periods presented are not necessarily indicative of the results expected for the full fiscal year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in its Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed with the SEC on April 1, 2013. |
Summary_of_Significant_Account1
Summary of Significant Accounting Policies (Tables) | 9 Months Ended | |||||||||||
Sep. 30, 2013 | ||||||||||||
Accounting Policies [Abstract] | ' | |||||||||||
Actual Percentages of Net Sales from Customer Whose Sales Represented Ten Percentage or More | ' | |||||||||||
The actual percentage of net sales derived from each customer whose sales represented 10% or more of the Company's consolidated net sales was as follows for the periods presented: | ||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||
2012 | 2013 | 2012 | 2013 | |||||||||
Customer A | 13 | % | 17 | % | 13 | % | 16 | % | ||||
Customer B | 15 | % | 14 | % | 16 | % | 14 | % | ||||
Customer C | 11 | % | 11 | % | 11 | % | 11 | % | ||||
Customer D | * | * | * | 10 | % | |||||||
Inventories_Tables
Inventories (Tables) | 9 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
Inventory Disclosure [Abstract] | ' | |||||||
Schedule of Inventories | ' | |||||||
Inventories consisted of the following at December 31, 2012 and September 30, 2013 (in thousands): | ||||||||
December 31, | September 30, | |||||||
2012 | 2013 | |||||||
Raw materials | $ | 12,100 | $ | 16,147 | ||||
Work-in-process | 27,779 | 30,409 | ||||||
Finished goods | 17,190 | 16,773 | ||||||
Total | $ | 57,069 | $ | 63,329 | ||||
Goodwill_and_intangible_assets1
Goodwill and intangible assets (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |||||||||||||||
Amortization Expense Related to Intangible Assets | ' | |||||||||||||||
For the three and nine months ended September 30, 2012 and 2013, the Company recorded amortization expense related to intangible assets as follows (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Cost of sales | $ | 497 | $ | 497 | $ | 1,491 | $ | 1,491 | ||||||||
Selling, general and administrative | 3,238 | 3,238 | 9,714 | 9,714 | ||||||||||||
Total | $ | 3,735 | $ | 3,735 | $ | 11,205 | $ | 11,205 | ||||||||
Schedule of Intangible Assets | ' | |||||||||||||||
Intangible assets consisted of the following at September 30, 2013 (in thousands): | ||||||||||||||||
Gross | Accumulated | Net | ||||||||||||||
Carrying | Amortization | Carrying | ||||||||||||||
Amount | Amount | |||||||||||||||
Developed technology and know how | $ | 16,991 | $ | (15,665 | ) | $ | 1,326 | |||||||||
Customer contracts and relationships | 197,575 | (104,758 | ) | 92,817 | ||||||||||||
Trade names and trademarks | 29,400 | — | 29,400 | |||||||||||||
Total intangible assets | $ | 243,966 | $ | (120,423 | ) | $ | 123,543 | |||||||||
Intangible assets consisted of the following at December 31, 2012 (in thousands): | ||||||||||||||||
Gross | Accumulated | Net | ||||||||||||||
Carrying | Amortization | Carrying | ||||||||||||||
Amount | Amount | |||||||||||||||
Developed technology and know how | $ | 16,991 | $ | (14,174 | ) | $ | 2,817 | |||||||||
Customer contracts and relationships | 197,575 | (95,045 | ) | 102,530 | ||||||||||||
Trade names and trademarks | 29,400 | — | 29,400 | |||||||||||||
Total intangible assets | $ | 243,966 | $ | (109,219 | ) | $ | 134,747 | |||||||||
Weighted-Average Amortization Periods | ' | |||||||||||||||
At December 31, 2012 and September 30, 2013, the remaining weighted-average amortization periods for the Company’s finite lived intangible assets were as follows (in years): | ||||||||||||||||
Remaining weighted - | ||||||||||||||||
average amortization period | ||||||||||||||||
December 31, | September 30, | |||||||||||||||
2012 | 2013 | |||||||||||||||
Developed technology and know how | 1.4 | 0.7 | ||||||||||||||
Customer contracts and relationships | 7.9 | 7.2 | ||||||||||||||
Total finite lived intangible assets | 7.7 | 7.1 |
Longterm_debt_Tables
Long-term debt (Tables) | 9 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
Debt Disclosure [Abstract] | ' | |||||||
Long-term Debt | ' | |||||||
Long-term debt consisted of the following at December 31, 2012 and September 30, 2013 (in thousands): | ||||||||
December 31, | September 30, | |||||||
2012 | 2013 | |||||||
Senior secured notes maturing on February 1, 2017, interest at 8.375% ("Senior Secured Notes") | $ | 400,000 | $ | 400,000 | ||||
Senior subordinated notes maturing on November 1, 2017, interest at 10.0% ("Senior Subordinated Notes") | 315,000 | 315,000 | ||||||
Capital lease obligations | 20 | 11 | ||||||
Total debt | 715,020 | 715,011 | ||||||
Less—unamortized discount | (1,715 | ) | (1,444 | ) | ||||
Less—current portion | (11 | ) | (7 | ) | ||||
Long term debt, excluding current portion | $ | 713,294 | $ | 713,560 | ||||
Restructuring_Tables
Restructuring (Tables) | 9 Months Ended | |||||||||||
Sep. 30, 2013 | ||||||||||||
Restructuring and Related Activities [Abstract] | ' | |||||||||||
Restructuring | ' | |||||||||||
The following table summarizes the amounts recorded related to restructuring activities, which are included in the accompanying unaudited condensed consolidated balance sheet as of September 30, 2012 (in thousands): | ||||||||||||
Employee | Other exit | Total | ||||||||||
costs | costs | |||||||||||
Balance, January 1, 2012 | $ | 340 | $ | — | $ | 340 | ||||||
Restructuring expenses | 1,577 | 975 | 2,552 | |||||||||
Payments | (698 | ) | (143 | ) | (841 | ) | ||||||
Balance, September 30, 2012 | $ | 1,219 | $ | 832 | $ | 2,051 | ||||||
The following table summarizes the amounts recorded related to restructuring activities, which are included in the accompanying unaudited condensed consolidated balance sheet as of September 30, 2013 (in thousands): | ||||||||||||
Employee | Other exit | Total | ||||||||||
costs | costs | |||||||||||
Balance, January 1, 2013 | $ | 1,329 | 790 | $ | 2,119 | |||||||
Restructuring expenses | (100 | ) | (15 | ) | (115 | ) | ||||||
Payments | (1,175 | ) | (119 | ) | (1,294 | ) | ||||||
Balance, September 30, 2013 | $ | 54 | $ | 656 | $ | 710 | ||||||
Divestitures_Tables
Divestitures (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Text Block [Abstract] | ' | |||||||||||||||
Schedule Of Discontinued Operations | ' | |||||||||||||||
Summary results of the discontinued operations were as follows (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Sales | $ | 2,501 | $ | — | $ | 13,745 | $ | — | ||||||||
Costs and expenses | 7,315 | 63 | 17,399 | 63 | ||||||||||||
Operating loss from discontinued operations | (4,814 | ) | (63 | ) | (3,654 | ) | (63 | ) | ||||||||
Other expenses, net | — | — | (6 | ) | — | |||||||||||
Loss from discontinued operations before income taxes | (4,814 | ) | (63 | ) | (3,660 | ) | (63 | ) | ||||||||
Provision for income taxes | 111 | — | 515 | — | ||||||||||||
Loss from discontinued operations, net of tax | $ | (4,925 | ) | $ | (63 | ) | $ | (4,175 | ) | $ | (63 | ) | ||||
Assets held for Sale | ||||||||||||||||
The Company is in the process of selling its facility located in Huntsville, Alabama. As of September 30, 2013, the property met the requirements to be classified as held for sale in the condensed consolidated balance sheet, and the sale is considered probable within the next twelve months. The assets had a net book value of approximately $1.1 million and $0.9 million as of December 31, 2012 and September 30, 2013, respectively. Assets measured at fair value on a non-recurring basis in the current period include the assets held for sale, as described in Note 11. |
Stockbased_compensation_Tables
Stock-based compensation (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||||||||
Activity Relating to Roll-Over Options During Period | ' | |||||||||||||||
The table below summarizes the activity relating to the Roll-Over options during the three months ended September 30, 2012 and 2013: | ||||||||||||||||
Three Months Ended | ||||||||||||||||
30-Sep-12 | 30-Sep-13 | |||||||||||||||
Liability | Roll-Over | Liability | Roll-Over | |||||||||||||
(in thousands) | Shares | (in thousands) | Shares | |||||||||||||
Outstanding | Outstanding | |||||||||||||||
Balance at July 1 | $ | 141 | 80,727 | $ | 141 | 80,727 | ||||||||||
Shares repurchased | — | — | — | — | ||||||||||||
Options exercised | — | — | — | — | ||||||||||||
Options forfeited | — | — | — | — | ||||||||||||
Change in fair value | — | — | — | — | ||||||||||||
Balance at end of period | $ | 141 | 80,727 | $ | 141 | 80,727 | ||||||||||
Assumptions to Determine Fair Value of Roll-Over Options | ' | |||||||||||||||
The Company used the following assumptions as of September 30, 2013 to determine the fair value of the Roll-Over options: | ||||||||||||||||
September 30, | ||||||||||||||||
2013 | ||||||||||||||||
Expected term to exercise | 0.50 years | |||||||||||||||
Expected volatility | 24.72 | % | ||||||||||||||
Risk-free rate | 0.33 | % | ||||||||||||||
Dividend yield | — | % | ||||||||||||||
Classification of Stock-Based Compensation | ' | |||||||||||||||
The following tables summarize the classification of recorded stock-based compensation in the unaudited condensed consolidated statements of operations and the recorded stock-based compensation by type of award for the three and nine months ended September 30, 2012 and 2013. | ||||||||||||||||
Classification of expense (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Cost of sales | $ | 43 | $ | 158 | $ | 81 | $ | 269 | ||||||||
Selling, general and administrative | 139 | 260 | 283 | 549 | ||||||||||||
Total | $ | 182 | $ | 418 | $ | 364 | $ | 818 | ||||||||
Stock-Based Compensation by Type of Award | ' | |||||||||||||||
Stock-based compensation related to stock awards by type of award (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Time-based vesting options | $ | 130 | $ | 316 | $ | 314 | $ | 508 | ||||||||
Restricted stock awards | 52 | 102 | 52 | 310 | ||||||||||||
Roll-over options | — | — | (2 | ) | — | |||||||||||
Total expense | $ | 182 | $ | 418 | $ | 364 | $ | 818 | ||||||||
Fair_value_measurements_Tables
Fair value measurements (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||
Summary of Financial Assets and Liabilities Recorded at Fair Value | ' | |||||||||||||||
The following tables provide a summary of the financial assets and liabilities recorded at fair value at December 31, 2012 and September 30, 2013 (in thousands): | ||||||||||||||||
Fair Value Measurements at | ||||||||||||||||
December 31, 2012 determined using | ||||||||||||||||
Total Carrying | Quoted Prices in | Significant Other | Significant | |||||||||||||
Value at | Active Markets | Observable | Unobservable | |||||||||||||
December 31, | for Identical | Inputs (Level 2) | Inputs | |||||||||||||
2012 | Assets (Level 1) | (Level 3) | ||||||||||||||
Investment in Available for Sale Security | $ | 210 | $ | 210 | $ | — | $ | — | ||||||||
Liability for Roll-Over options | $ | 141 | $ | — | $ | — | $ | 141 | ||||||||
Fair Value Measurements at | ||||||||||||||||
September 30, 2013 determined using | ||||||||||||||||
Total Carrying | Quoted Prices in | Significant Other | Significant | |||||||||||||
Value at | Active Markets | Observable | Unobservable | |||||||||||||
September 30, | for Identical | Inputs (Level 2) | Inputs | |||||||||||||
2013 | Assets (Level 1) | (Level 3) | ||||||||||||||
Liability for Roll-Over options | $ | 141 | $ | — | $ | — | $ | 141 | ||||||||
Supplemental_guarantor_condens1
Supplemental guarantor condensed consolidating financial statements (Tables) | 9 Months Ended | |||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||
Condensed Financial Information of Parent Company Only Disclosure [Abstract] | ' | |||||||||||||||||||
Statements of Operations | ' | |||||||||||||||||||
Unaudited Condensed Consolidating Statements of Operations — | ||||||||||||||||||||
Three months ended September 30, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net sales | $ | — | $ | 115,587 | $ | 10,939 | $ | (565 | ) | $ | 125,961 | |||||||||
Cost of sales (exclusive of amortization) | — | 85,095 | 7,720 | (565 | ) | 92,250 | ||||||||||||||
Selling, general and administrative expenses | 23 | 11,918 | 892 | — | 12,833 | |||||||||||||||
Research and development expenses | — | 210 | 209 | — | 419 | |||||||||||||||
Restructuring expenses | — | 714 | — | — | 714 | |||||||||||||||
Amortization of intangible assets | 3,735 | — | — | — | 3,735 | |||||||||||||||
(Gain) loss on disposal of assets | — | (223 | ) | 2 | — | (221 | ) | |||||||||||||
(Loss) income from continuing operations | (3,758 | ) | 17,873 | 2,116 | — | 16,231 | ||||||||||||||
Interest (expense) income, net | (17,363 | ) | 656 | (672 | ) | — | (17,379 | ) | ||||||||||||
Other income, net | — | 167 | 425 | — | 592 | |||||||||||||||
Equity in earnings (losses) of affiliates | 19,772 | 1,313 | — | (21,085 | ) | — | ||||||||||||||
(Loss) income from continuing operations before income taxes | (1,349 | ) | 20,009 | 1,869 | (21,085 | ) | (556 | ) | ||||||||||||
Provision for income taxes | — | 443 | 556 | — | 999 | |||||||||||||||
Net (loss) income from continuing operations | (1,349 | ) | 19,566 | 1,313 | (21,085 | ) | (1,555 | ) | ||||||||||||
Net (loss) income from discontinued operations, net of tax | (5,131 | ) | 206 | — | — | (4,925 | ) | |||||||||||||
Net (loss) income | $ | (6,480 | ) | $ | 19,772 | $ | 1,313 | $ | (21,085 | ) | $ | (6,480 | ) | |||||||
Unaudited Condensed Consolidating Statements of Operations — | ||||||||||||||||||||
Three months ended September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net sales | $ | — | $ | 123,983 | $ | 11,864 | $ | (410 | ) | $ | 135,437 | |||||||||
Cost of sales (exclusive of amortization) | — | 89,848 | 8,123 | (410 | ) | 97,561 | ||||||||||||||
Selling, general and administrative expenses | 30 | 11,594 | 887 | — | 12,511 | |||||||||||||||
Research and development expenses | — | 294 | 214 | — | 508 | |||||||||||||||
Impairment of goodwill | — | — | — | — | — | |||||||||||||||
Restructuring expenses | — | 66 | — | — | 66 | |||||||||||||||
Amortization of intangible assets | 3,735 | — | — | — | 3,735 | |||||||||||||||
Loss on disposal of assets | — | 148 | 56 | — | 204 | |||||||||||||||
(Loss) income from continuing operations | (3,765 | ) | 22,033 | 2,584 | — | 20,852 | ||||||||||||||
Interest (expense) income, net | (17,287 | ) | 715 | (716 | ) | — | (17,288 | ) | ||||||||||||
Other income (expense), net | — | 1,160 | (1,263 | ) | — | (103 | ) | |||||||||||||
Equity in earnings of affiliates | 23,415 | 202 | — | (23,617 | ) | — | ||||||||||||||
Income (loss) from continuing operations before income taxes | 2,363 | 24,110 | 605 | (23,617 | ) | 3,461 | ||||||||||||||
Provision for income taxes | — | 632 | 403 | — | 1,035 | |||||||||||||||
Net income (loss) from continuing operations | 2,363 | 23,478 | 202 | (23,617 | ) | 2,426 | ||||||||||||||
Net loss from discontinued operations, net of tax | — | (63 | ) | — | — | (63 | ) | |||||||||||||
Net income (loss) | $ | 2,363 | $ | 23,415 | $ | 202 | $ | (23,617 | ) | $ | 2,363 | |||||||||
Unaudited Condensed Consolidating Statements of Operations — | ||||||||||||||||||||
Nine months ended September 30, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net sales | $ | — | $ | 346,842 | $ | 31,397 | $ | (1,713 | ) | $ | 376,526 | |||||||||
Cost of sales (exclusive of amortization) | — | 260,184 | 21,899 | (1,713 | ) | 280,370 | ||||||||||||||
Selling, general and administrative expenses | 69 | 38,702 | 2,731 | — | 41,502 | |||||||||||||||
Research and development expenses | — | 707 | 657 | — | 1,364 | |||||||||||||||
Restructuring expenses | — | 2,552 | — | — | 2,552 | |||||||||||||||
Amortization of intangible assets | 11,205 | — | — | — | 11,205 | |||||||||||||||
(Gain) loss on disposal of assets | — | (264 | ) | 10 | — | (254 | ) | |||||||||||||
(Loss) income from continuing operations | (11,274 | ) | 44,961 | 6,100 | — | 39,787 | ||||||||||||||
Interest (expense) income, net | (51,812 | ) | 1,997 | (2,064 | ) | — | (51,879 | ) | ||||||||||||
Other (expense) income, net | — | (1,154 | ) | 1,064 | — | (90 | ) | |||||||||||||
Equity in earnings of affiliates | 49,143 | 3,273 | — | (52,416 | ) | — | ||||||||||||||
(Loss) income from continuing operations before income taxes | (13,943 | ) | 49,077 | 5,100 | (52,416 | ) | (12,182 | ) | ||||||||||||
Provision for income taxes | — | 890 | 1,827 | — | 2,717 | |||||||||||||||
Net (loss) income from continuing operations | (13,943 | ) | 48,187 | 3,273 | (52,416 | ) | (14,899 | ) | ||||||||||||
Net (loss) income from discontinued operations, net of tax | (5,131 | ) | 956 | — | — | (4,175 | ) | |||||||||||||
Net (loss) income | $ | (19,074 | ) | $ | 49,143 | $ | 3,273 | $ | (52,416 | ) | $ | (19,074 | ) | |||||||
Unaudited Condensed Consolidating Statements of Operations — | ||||||||||||||||||||
Nine months ended September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net sales | $ | — | $ | 355,194 | $ | 32,827 | $ | (1,053 | ) | $ | 386,968 | |||||||||
Cost of sales (exclusive of amortization) | — | 265,785 | 23,087 | (1,053 | ) | 287,819 | ||||||||||||||
Selling, general and administrative expenses | 92 | 36,746 | 2,698 | — | 39,536 | |||||||||||||||
Research and development expenses | — | 919 | 588 | — | 1,507 | |||||||||||||||
Impairment of goodwill | 63,128 | — | — | — | 63,128 | |||||||||||||||
Restructuring expenses | — | (115 | ) | — | — | (115 | ) | |||||||||||||
Amortization of intangible assets | 11,205 | — | — | — | 11,205 | |||||||||||||||
Loss on disposal of assets | — | 814 | 82 | — | 896 | |||||||||||||||
(Loss) income from continuing operations | (74,425 | ) | 51,045 | 6,372 | — | (17,008 | ) | |||||||||||||
Interest (expense) income, net | (51,867 | ) | 2,123 | (2,121 | ) | — | (51,865 | ) | ||||||||||||
Other income (expense), net | 923 | 306 | (1,512 | ) | — | (283 | ) | |||||||||||||
Equity in earnings of affiliates | 52,992 | 1,649 | — | (54,641 | ) | — | ||||||||||||||
(Loss) income from continuing operations before income taxes | (72,377 | ) | 55,123 | 2,739 | (54,641 | ) | (69,156 | ) | ||||||||||||
Provision for income taxes | — | 2,068 | 1,090 | — | 3,158 | |||||||||||||||
Net (loss) income from continuing operations | (72,377 | ) | 53,055 | 1,649 | (54,641 | ) | (72,314 | ) | ||||||||||||
Net loss from discontinued operations, net of tax | — | (63 | ) | — | — | (63 | ) | |||||||||||||
Net (loss) income | $ | (72,377 | ) | $ | 52,992 | $ | 1,649 | $ | (54,641 | ) | $ | (72,377 | ) | |||||||
Balance Sheets | ' | |||||||||||||||||||
Unaudited Condensed Consolidating Balance Sheets | ||||||||||||||||||||
December 31, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Cash | $ | — | $ | 53,812 | $ | 6,090 | $ | — | $ | 59,902 | ||||||||||
Accounts receivable, net | — | 46,992 | 2,929 | (518 | ) | 49,403 | ||||||||||||||
Inventories | — | 52,807 | 4,262 | — | 57,069 | |||||||||||||||
Prepaid expenses and other current assets | 215 | 10,399 | 359 | — | 10,973 | |||||||||||||||
Total current assets | 215 | 164,010 | 13,640 | (518 | ) | 177,347 | ||||||||||||||
Property, plant and equipment, net | — | 89,413 | 25,396 | — | 114,809 | |||||||||||||||
Assets held for sale | — | 1,060 | — | — | 1,060 | |||||||||||||||
Intercompany receivables, net | — | 365,713 | — | (365,713 | ) | — | ||||||||||||||
Investment in subsidiaries | 554,794 | 9,143 | — | (563,937 | ) | — | ||||||||||||||
Goodwill | 619,443 | — | — | — | 619,443 | |||||||||||||||
Other intangible assets, net | 134,747 | — | — | — | 134,747 | |||||||||||||||
Deferred financing costs and other assets, net | 13,269 | (8 | ) | 505 | — | 13,766 | ||||||||||||||
Total assets | $ | 1,322,468 | $ | 629,331 | $ | 39,541 | $ | (930,168 | ) | $ | 1,061,172 | |||||||||
Current portion of long-term debt | $ | — | $ | 11 | $ | — | $ | — | $ | 11 | ||||||||||
Accounts payable | 1 | 18,613 | 1,948 | (518 | ) | 20,044 | ||||||||||||||
Accrued expenses and other current liabilities | 19,317 | 20,267 | 3,927 | — | 43,511 | |||||||||||||||
Total current liabilities | 19,318 | 38,891 | 5,875 | (518 | ) | 63,566 | ||||||||||||||
Long-term debt | 1,057,832 | — | 21,175 | (365,713 | ) | 713,294 | ||||||||||||||
Other long-term liabilities | 911 | 35,646 | 3,348 | — | 39,905 | |||||||||||||||
Total liabilities | 1,078,061 | 74,537 | 30,398 | (366,231 | ) | 816,765 | ||||||||||||||
Equity | 244,407 | 554,794 | 9,143 | (563,937 | ) | 244,407 | ||||||||||||||
Total liabilities and equity | $ | 1,322,468 | $ | 629,331 | $ | 39,541 | $ | (930,168 | ) | $ | 1,061,172 | |||||||||
Unaudited Condensed Consolidating Balance Sheets | ||||||||||||||||||||
September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Cash | $ | — | $ | 56,651 | $ | 7,926 | $ | — | $ | 64,577 | ||||||||||
Accounts receivable, net | — | 52,603 | 4,559 | (427 | ) | 56,735 | ||||||||||||||
Inventories | — | 58,232 | 5,097 | — | 63,329 | |||||||||||||||
Prepaid expenses and other current assets | 24 | 3,095 | 284 | — | 3,403 | |||||||||||||||
Total current assets | 24 | 170,581 | 17,866 | (427 | ) | 188,044 | ||||||||||||||
Property, plant and equipment, net | — | 87,721 | 28,594 | — | 116,315 | |||||||||||||||
Assets held for sale | — | 880 | — | — | 880 | |||||||||||||||
Intercompany receivables, net | — | 417,205 | — | (417,205 | ) | — | ||||||||||||||
Investment in subsidiaries | 608,507 | 11,523 | — | (620,030 | ) | — | ||||||||||||||
Goodwill | 556,315 | — | — | — | 556,315 | |||||||||||||||
Other intangible assets, net | 123,543 | — | — | — | 123,543 | |||||||||||||||
Deferred financing costs and other assets, net | 11,090 | 64 | 480 | — | 11,634 | |||||||||||||||
Total assets | $ | 1,299,479 | $ | 687,974 | $ | 46,940 | $ | (1,037,662 | ) | $ | 996,731 | |||||||||
Current portion of long-term debt | $ | — | $ | 7 | $ | — | $ | — | $ | 7 | ||||||||||
Accounts payable | — | 20,845 | 1,841 | (427 | ) | 22,259 | ||||||||||||||
Accrued expenses and other current liabilities | 18,804 | 22,098 | 5,583 | — | 46,485 | |||||||||||||||
Total current liabilities | 18,804 | 42,950 | 7,424 | (427 | ) | 68,751 | ||||||||||||||
Long-term debt | 1,106,313 | — | 24,452 | (417,205 | ) | 713,560 | ||||||||||||||
Other long-term liabilities | 926 | 36,517 | 3,541 | — | 40,984 | |||||||||||||||
Total liabilities | 1,126,043 | 79,467 | 35,417 | (417,632 | ) | 823,295 | ||||||||||||||
Equity | 173,436 | 608,507 | 11,523 | (620,030 | ) | 173,436 | ||||||||||||||
Total liabilities and equity | $ | 1,299,479 | $ | 687,974 | $ | 46,940 | $ | (1,037,662 | ) | $ | 996,731 | |||||||||
Statements of Comprehensive Income (Loss) | ' | |||||||||||||||||||
Unaudited Condensed Consolidating Statements of Comprehensive (Loss) Income | ||||||||||||||||||||
Three months ended September 30, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net (loss) income | $ | (6,480 | ) | $ | 19,772 | $ | 1,313 | $ | (21,085 | ) | $ | (6,480 | ) | |||||||
Other comprehensive income (loss): | ||||||||||||||||||||
Unrealized gain on available for sale security | (250 | ) | — | — | — | (250 | ) | |||||||||||||
Cumulative translation adjustment | 344 | 163 | 181 | (344 | ) | 344 | ||||||||||||||
Comprehensive (loss) income | $ | (6,386 | ) | $ | 19,935 | $ | 1,494 | $ | (21,429 | ) | $ | (6,386 | ) | |||||||
Unaudited Condensed Consolidating Statements of Comprehensive (Loss) Income | ||||||||||||||||||||
Three months ended September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net income | $ | 2,363 | $ | 23,415 | $ | 202 | $ | (23,617 | ) | $ | 2,363 | |||||||||
Other comprehensive income (loss): | ||||||||||||||||||||
Cumulative translation adjustment | 655 | 269 | 386 | (655 | ) | 655 | ||||||||||||||
Comprehensive income | $ | 3,018 | $ | 23,684 | $ | 588 | $ | (24,272 | ) | $ | 3,018 | |||||||||
Unaudited Condensed Consolidating Statements of Comprehensive (Loss) Income | ||||||||||||||||||||
Nine months ended September 30, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net (loss) income | $ | (19,074 | ) | $ | 49,143 | $ | 3,273 | $ | (52,416 | ) | $ | (19,074 | ) | |||||||
Other comprehensive income (loss): | ||||||||||||||||||||
Unrealized gain on available for sale security | (57 | ) | — | — | — | (57 | ) | |||||||||||||
Cumulative translation adjustment | 358 | 218 | 140 | (358 | ) | 358 | ||||||||||||||
Comprehensive (loss) income | $ | (18,773 | ) | $ | 49,361 | $ | 3,413 | $ | (52,774 | ) | $ | (18,773 | ) | |||||||
Unaudited Condensed Consolidating Statements of Comprehensive (Loss) Income | ||||||||||||||||||||
Nine months ended September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net (loss) income | $ | (72,377 | ) | $ | 52,992 | $ | 1,649 | $ | (54,641 | ) | $ | (72,377 | ) | |||||||
Other comprehensive income (loss): | ||||||||||||||||||||
Unrealized gain on available for sale security | 32 | — | — | — | 32 | |||||||||||||||
Realized gain on available for sale security | (242 | ) | — | — | — | (242 | ) | |||||||||||||
Cumulative translation adjustment | 723 | (8 | ) | 731 | (723 | ) | 723 | |||||||||||||
Comprehensive (loss) income | $ | (71,864 | ) | $ | 52,984 | $ | 2,380 | $ | (55,364 | ) | $ | (71,864 | ) | |||||||
Statements of Cash Flows | ' | |||||||||||||||||||
Unaudited Condensed Consolidating Statements of Cash Flows — | ||||||||||||||||||||
Nine months ended September 30, 2012 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net cash (used in) provided by operating activities of continuing operations | $ | (49,930 | ) | $ | 59,628 | $ | 4,048 | $ | — | $ | 13,746 | |||||||||
Net cash provided by operating activities of discontinued operations | — | 2,406 | — | — | 2,406 | |||||||||||||||
Net cash (used in) provided by operating activities | (49,930 | ) | 62,034 | 4,048 | — | 16,152 | ||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||||
Capital expenditures | — | (4,552 | ) | (8,628 | ) | — | (13,180 | ) | ||||||||||||
Proceeds from disposition of assets | — | 264 | — | — | 264 | |||||||||||||||
Net cash used in investing activities of continuing operations | — | (4,288 | ) | (8,628 | ) | — | (12,916 | ) | ||||||||||||
Net cash provided by investing activities of discontinued operations | — | 7,484 | — | — | 7,484 | |||||||||||||||
Net cash provided by (used in) investing activities | — | 3,196 | (8,628 | ) | — | (5,432 | ) | |||||||||||||
Cash flows from financing activities: | ||||||||||||||||||||
Repayments of long-term debt and capital lease obligations | — | (14 | ) | (2 | ) | — | (16 | ) | ||||||||||||
Intercompany receipts (advances) | 49,973 | (53,379 | ) | 3,406 | — | — | ||||||||||||||
Repurchase of parent company stock | (43 | ) | — | — | — | (43 | ) | |||||||||||||
Cash flows provided by (used in) financing activities | 49,930 | (53,393 | ) | 3,404 | — | (59 | ) | |||||||||||||
Effect of exchange rate changes in cash | — | 86 | (18 | ) | — | 68 | ||||||||||||||
Net increase (decrease) in cash | — | 11,923 | (1,194 | ) | — | 10,729 | ||||||||||||||
Cash, beginning of period | — | 32,627 | 6,231 | — | 38,858 | |||||||||||||||
Cash, end of period | $ | — | $ | 44,550 | $ | 5,037 | $ | — | $ | 49,587 | ||||||||||
Unaudited Condensed Consolidating Statements of Cash Flows — | ||||||||||||||||||||
Nine months ended September 30, 2013 (in thousands): | ||||||||||||||||||||
Parent | Subsidiary | Non- | Eliminations | Consolidated | ||||||||||||||||
Guarantors | Guarantor | |||||||||||||||||||
Subsidiaries | ||||||||||||||||||||
Net cash (used in) provided by operating activities of continuing operations | $ | (48,325 | ) | $ | 56,307 | $ | 4,635 | $ | — | $ | 12,617 | |||||||||
Net cash used in operating activities of discontinued operations | — | (265 | ) | — | — | (265 | ) | |||||||||||||
Net cash (used in) provided by operating activities | (48,325 | ) | 56,042 | 4,635 | — | 12,352 | ||||||||||||||
Cash flows from investing activities: | ||||||||||||||||||||
Capital expenditures | — | (9,877 | ) | (6,316 | ) | — | (16,193 | ) | ||||||||||||
Proceeds from sale of equipment | — | 61 | 7 | — | 68 | |||||||||||||||
Proceeds from the sale of available for sale securities | 242 | — | — | — | 242 | |||||||||||||||
Net cash provided by (used in) investing activities of continuing operations | 242 | (9,816 | ) | (6,309 | ) | — | (15,883 | ) | ||||||||||||
Net cash provided by investing activities of discontinued operations | — | 7,987 | — | — | 7,987 | |||||||||||||||
Net cash provided by (used in) investing activities | 242 | (1,829 | ) | (6,309 | ) | — | (7,896 | ) | ||||||||||||
Cash flows from financing activities: | ||||||||||||||||||||
Repayments of long-term debt and capital lease obligations | — | (9 | ) | — | — | (9 | ) | |||||||||||||
Intercompany receipts (advances) | 48,083 | (51,357 | ) | 3,274 | — | — | ||||||||||||||
Cash flows provided by (used in) financing activities | 48,083 | (51,366 | ) | 3,274 | — | (9 | ) | |||||||||||||
Effect of exchange rate changes in cash | — | (8 | ) | 236 | — | 228 | ||||||||||||||
Net increase in cash | — | 2,839 | 1,836 | — | 4,675 | |||||||||||||||
Cash, beginning of period | — | 53,812 | 6,090 | — | 59,902 | |||||||||||||||
Cash, end of period | $ | — | $ | 56,651 | $ | 7,926 | $ | — | $ | 64,577 | ||||||||||
Changes_in_Stockholders_Equity1
Changes in Stockholders' Equity (Tables) | 9 Months Ended | ||||||||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | ' | ||||||||||||||||||||||
Summary of Changes in Stockholders' Equity | ' | ||||||||||||||||||||||
The following table summarizes the changes in stockholders’ equity during the nine months ended September 30, 2013 (in thousands except share data): | |||||||||||||||||||||||
Common Stock | Additional | Accumulated | Accumulated | Total | |||||||||||||||||||
Paid-In | other | (deficit) | Equity | ||||||||||||||||||||
Capital | comprehensive | ||||||||||||||||||||||
Shares | Amount | income (loss) | |||||||||||||||||||||
Balance, January 1, 2013 | 1,000 | $ | — | $ | 639,610 | $ | (2,554 | ) | $ | (392,649 | ) | $ | 244,407 | ||||||||||
Comprehensive loss: | |||||||||||||||||||||||
Net loss | — | — | — | (72,377 | ) | (72,377 | ) | ||||||||||||||||
Unrealized gain on available for sale security | — | — | 32 | — | 32 | ||||||||||||||||||
Realized gain on available for sale security | — | — | (242 | ) | — | (242 | ) | ||||||||||||||||
Cumulative translation adjustment | — | — | 723 | — | 723 | ||||||||||||||||||
Total comprehensive loss | (71,864 | ) | |||||||||||||||||||||
Stock-based compensation and other | — | 893 | — | — | 893 | ||||||||||||||||||
Balance, September 30, 2013 | 1,000 | $ | — | $ | 640,503 | $ | (2,041 | ) | $ | (465,026 | ) | $ | 173,436 | ||||||||||
Changes_in_Accumulated_Other_C1
Changes in Accumulated Other Comprehensive Loss (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Equity [Abstract] | ' | |||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) | ' | |||||||||||||||
The following table summarizes the changes in accumulated other comprehensive (loss) income for the nine months ended September 30, 2012 (in thousands): | ||||||||||||||||
Defined Benefit Pension Items | Unrealized Gains and Losses on Available-for-Sale Securities | Foreign Currency Items | Total | |||||||||||||
Balance at January 1, 2012 | $ | (317 | ) | $ | 1,155 | $ | (2,104 | ) | $ | (1,266 | ) | |||||
Other comprehensive (loss) income before reclassifications | — | (57 | ) | 358 | 301 | |||||||||||
Amounts reclassified from accumulated other comprehensive income | — | — | — | — | ||||||||||||
Net current-period other comprehensive (loss) income | — | (57 | ) | 358 | 301 | |||||||||||
Balance at September 30, 2012 | $ | (317 | ) | $ | 1,098 | $ | (1,746 | ) | $ | (965 | ) | |||||
The following table summarizes the changes in accumulated other comprehensive (loss) income for the nine months ended September 30, 2013 (in thousands): | ||||||||||||||||
Defined Benefit Pension Items | Unrealized Gains and Losses on Available-for-Sale Securities | Foreign Currency Items | Total | |||||||||||||
Balance at January 1, 2013 | $ | (1,159 | ) | $ | 210 | $ | (1,605 | ) | $ | (2,554 | ) | |||||
Other comprehensive (loss) income before reclassifications | — | (210 | ) | 723 | 513 | |||||||||||
Amounts reclassified from accumulated other comprehensive income | — | — | — | — | ||||||||||||
Net current-period other comprehensive (loss) income | — | (210 | ) | 723 | 513 | |||||||||||
Balance at September 30, 2013 | $ | (1,159 | ) | $ | — | $ | (882 | ) | $ | (2,041 | ) | |||||
Segment_Information_Tables
Segment Information (Tables) | 9 Months Ended | |||||||||||||||
Sep. 30, 2013 | ||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||
Schedule of segment income (loss) from operations | ' | |||||||||||||||
The Company's net sales and Adjusted EBITDA by segment as well as a reconciliation of Total Adjusted EBITDA to the consolidated loss from continuing operations before provision for income taxes is as follows (in thousands): | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
September 30, | September 30, | September 30, | September 30, | |||||||||||||
2012 | 2013 | 2012 | 2013 | |||||||||||||
Net sales: | ||||||||||||||||
Cardio & Vascular | $ | 79,550 | $ | 83,337 | $ | 236,235 | $ | 240,505 | ||||||||
Advanced Surgical | 48,996 | 53,169 | 147,170 | 148,827 | ||||||||||||
Intersegment | (2,585 | ) | (1,069 | ) | (6,879 | ) | (2,364 | ) | ||||||||
Total net sales | $ | 125,961 | $ | 135,437 | $ | 376,526 | $ | 386,968 | ||||||||
Adjusted EBITDA: | ||||||||||||||||
Cardio & Vascular | $ | 25,307 | $ | 26,852 | $ | 72,758 | $ | 72,568 | ||||||||
Advanced Surgical | 8,470 | 9,493 | 22,586 | 22,638 | ||||||||||||
Corporate Services | (5,625 | ) | (5,761 | ) | (19,400 | ) | (18,569 | ) | ||||||||
Total Adjusted EBITDA | $ | 28,152 | $ | 30,584 | $ | 75,944 | $ | 76,637 | ||||||||
Reconciliation of Adjusted EBITDA to income (loss) from continuing operations before provision for income taxes | ||||||||||||||||
Impairment of goodwill | $ | — | $ | — | $ | — | $ | (63,128 | ) | |||||||
Interest expense, net | (17,379 | ) | (17,288 | ) | (51,879 | ) | (51,865 | ) | ||||||||
Depreciation and amortization | (10,090 | ) | (8,406 | ) | (29,578 | ) | (24,634 | ) | ||||||||
Stock-based compensation - employees | (182 | ) | (418 | ) | (364 | ) | (818 | ) | ||||||||
Stock-based compensation - non-employees | (23 | ) | (30 | ) | (68 | ) | (90 | ) | ||||||||
Employee severance and relocation | (500 | ) | (152 | ) | (1,870 | ) | (971 | ) | ||||||||
Restructuring expenses | (714 | ) | (66 | ) | (2,552 | ) | 115 | |||||||||
Plant closure costs & other | (194 | ) | (27 | ) | (517 | ) | (1,244 | ) | ||||||||
Currency gain (loss) | 568 | (111 | ) | (152 | ) | (1,231 | ) | |||||||||
Gain (loss) on disposal of property and equipment | 221 | (204 | ) | 254 | (896 | ) | ||||||||||
Other taxes | (80 | ) | (70 | ) | (395 | ) | (218 | ) | ||||||||
Management fees to stockholder | (335 | ) | (351 | ) | (1,005 | ) | (1,055 | ) | ||||||||
Realized gain on available for sale security | — | — | — | 242 | ||||||||||||
Total adjustments | $ | (28,708 | ) | $ | (27,123 | ) | $ | (88,126 | ) | $ | (145,793 | ) | ||||
Income (loss) from continuing operations before provision for income taxes | $ | (556 | ) | $ | 3,461 | $ | (12,182 | ) | $ | (69,156 | ) | |||||
Reconciliation of capital expenditures | ' | |||||||||||||||
The Company's capital expenditures by segment at September 30, 2012 and September 30, 2013 are as follows (in thousands): | ||||||||||||||||
Nine Months Ended | ||||||||||||||||
September 30, | September 30, | |||||||||||||||
2012 | 2013 | |||||||||||||||
Capital expenditures: | ||||||||||||||||
Cardio & Vascular | $ | 6,191 | $ | 8,144 | ||||||||||||
Advanced Surgical | 6,279 | 7,769 | ||||||||||||||
Corporate | 710 | 280 | ||||||||||||||
Total capital expenditures | $ | 13,180 | $ | 16,193 | ||||||||||||
Reconciliation of assets | ' | |||||||||||||||
The Company's assets by segment at December 31, 2012 and September 30, 2013 are as follows (in thousands): | ||||||||||||||||
December 31, | September 30, | |||||||||||||||
2012 | 2013 | |||||||||||||||
Assets: | ||||||||||||||||
Cardio & Vascular | $ | 606,304 | $ | 619,541 | ||||||||||||
Advanced Surgical | 245,619 | 181,577 | ||||||||||||||
Corporate Services | 209,249 | 195,613 | ||||||||||||||
Total assets | $ | 1,061,172 | $ | 996,731 | ||||||||||||
Recovered_Sheet2
Summary of significant accounting policies - Additional Information (Detail) | 3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | |||||||||
Sep. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2012 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | |
Customer | segment | Customer | Customer | Customer A [Member] | Customer B [Member] | Net sales [Member] | Net sales [Member] | Net sales [Member] | Net sales [Member] | Customer Concentration Risk [Member] | Customer Concentration Risk [Member] | Customer Concentration Risk [Member] | |
segment | Accounts Receivable [Member] | Accounts Receivable [Member] | Customer A [Member] | Customer C [Member] | Customer D [Member] | ||||||||
Accounts Receivable [Member] | Accounts Receivable [Member] | Accounts Receivable [Member] | |||||||||||
Revenue, Major Customer [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of reportable segments | ' | 2 | 2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of customers accounted for approximate net sales | 10 | ' | 10 | 10 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Approximate sales percentage accounted from company's ten largest customers of company's consolidated net sales | ' | ' | ' | ' | ' | ' | 66.00% | 62.00% | 67.00% | 64.00% | ' | ' | ' |
Concentration risk percentage | ' | ' | ' | ' | 13.00% | 12.00% | ' | ' | ' | ' | 19.00% | 10.00% | 10.00% |
Summary_of_significant_account2
Summary of significant accounting policies - Actual Percentages of Net Sales from Customer Whose Sales Represented Ten Percentage or More (Detail) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | |
Customer A [Member] | ' | ' | ' | ' |
Revenue, Major Customer [Line Items] | ' | ' | ' | ' |
Percentages of net sales | 17.00% | 13.00% | 16.00% | 13.00% |
Customer B [Member] | ' | ' | ' | ' |
Revenue, Major Customer [Line Items] | ' | ' | ' | ' |
Percentages of net sales | 14.00% | 15.00% | 14.00% | 16.00% |
Customer C [Member] | ' | ' | ' | ' |
Revenue, Major Customer [Line Items] | ' | ' | ' | ' |
Percentages of net sales | 11.00% | 11.00% | 11.00% | 11.00% |
Customer D [Member] | ' | ' | ' | ' |
Revenue, Major Customer [Line Items] | ' | ' | ' | ' |
Percentages of net sales | ' | ' | 10.00% | ' |
Inventories_Schedule_of_Invent
Inventories - Schedule of Inventories (Detail) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Inventory Disclosure [Abstract] | ' | ' |
Raw materials | $16,147 | $12,100 |
Work-in-process | 30,409 | 27,779 |
Finished goods | 16,773 | 17,190 |
Total | $63,329 | $57,069 |
Goodwill_and_intangible_assets2
Goodwill and intangible assets - Additional Information (Detail) (USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | |
segment | segment | ||||||
Goodwill [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Number of reportable segments | ' | ' | 2 | ' | 2 | ' | ' |
Goodwill | $556,315,000 | ' | ' | ' | $556,315,000 | ' | $619,443,000 |
Goodwill impairment charges recorded | 0 | 12,100,000 | 51,000,000 | 0 | 63,128,000 | 0 | 0 |
Estimated intangible asset amortization expense for the remainder of 2013 | 3,700,000 | ' | ' | ' | 3,700,000 | ' | ' |
Estimated annual intangible asset amortization expense in 2014 | 13,800,000 | ' | ' | ' | 13,800,000 | ' | ' |
Estimated annual intangible asset amortization expense in 2015 | 13,000,000 | ' | ' | ' | 13,000,000 | ' | ' |
Estimated annual intangible asset amortization expense in 2016 | 13,000,000 | ' | ' | ' | 13,000,000 | ' | ' |
Estimated intangible asset amortization expense approximates in 2017 | 13,000,000 | ' | ' | ' | 13,000,000 | ' | ' |
Estimated intangible asset amortization expense, thereafter | 37,600,000 | ' | ' | ' | 37,600,000 | ' | ' |
Advanced Surgical [Member] | ' | ' | ' | ' | ' | ' | ' |
Goodwill [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Goodwill | ' | ' | 134,000,000 | ' | ' | ' | ' |
Goodwill impairment charges recorded | ' | ' | 16,000,000 | ' | ' | ' | ' |
Cardio and Vascular [Member] | ' | ' | ' | ' | ' | ' | ' |
Goodwill [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Goodwill | ' | ' | $485,400,000 | ' | ' | ' | ' |
Goodwill_and_intangible_assets3
Goodwill and intangible assets - Amortization Expense Related to Intangible Assets (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Amortization of intangible assets | $3,735 | $3,735 | $11,205 | $11,205 |
Cost of sales | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Amortization of intangible assets | 497 | 497 | 1,491 | 1,491 |
Selling, general and administrative | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Amortization of intangible assets | $3,238 | $3,238 | $9,714 | $9,714 |
Goodwill_and_intangible_assets4
Goodwill and intangible assets - Intangible Assets (Detail) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Gross Carrying Amount | $243,966 | $243,966 |
Accumulated Amortization | -120,423 | -109,219 |
Net Carrying Amount | 123,543 | 134,747 |
Developed technology and know how [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Gross Carrying Amount | 16,991 | 16,991 |
Accumulated Amortization | -15,665 | -14,174 |
Net Carrying Amount | 1,326 | 2,817 |
Customer contracts and relationships [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Gross Carrying Amount | 197,575 | 197,575 |
Accumulated Amortization | -104,758 | -95,045 |
Net Carrying Amount | 92,817 | 102,530 |
Trade names and trademarks [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Gross Carrying Amount | 29,400 | 29,400 |
Accumulated Amortization | 0 | 0 |
Net Carrying Amount | $29,400 | $29,400 |
Goodwill_and_intangible_assets5
Goodwill and intangible assets - Weighted-Average Amortization Periods (Detail) | Sep. 30, 2013 | Dec. 31, 2012 |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Remaining weighted-average amortization period (years) | '7 years 1 month 6 days | '7 years 8 months 12 days |
Developed technology and know how [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Remaining weighted-average amortization period (years) | '8 months 12 days | '1 year 4 months 24 days |
Customer contracts and relationships [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Remaining weighted-average amortization period (years) | '7 years 2 months 12 days | '7 years 10 months 24 days |
Longterm_debt_Schedule_of_Long
Long-term debt - Schedule of Long-term Debt (Detail) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Debt Instrument [Line Items] | ' | ' |
Long-term Debt, Gross | $715,011 | $715,020 |
Less-unamortized discount | -1,444 | -1,715 |
Less-current portion | -7 | -11 |
Long term debt, excluding current portion | 713,560 | 713,294 |
Senior Secured Notes | Senior Secured Notes Maturing on February 1, 2017, Interest at 8.375% | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Long-term Debt, Gross | 400,000 | 400,000 |
Subordinated Debt | Senior Subordinated Notes Maturing on November 1, 2017, Interest at 10.0% | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Long-term Debt, Gross | 315,000 | 315,000 |
Capital Lease Obligations | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Long-term Debt, Gross | $11 | $20 |
Longterm_debt_Longterm_Debt_Pa
Long-term debt - Long-term Debt (Parenthetical) (Detail) | 9 Months Ended |
Sep. 30, 2013 | |
Senior Secured Notes | ' |
Schedule of Investments [Line Items] | ' |
Interest rate | 8.38% |
Maturity date | 1-Feb-17 |
2017 Subordinated Notes | ' |
Schedule of Investments [Line Items] | ' |
Interest rate | 10.00% |
Maturity date | 1-Nov-17 |
Longterm_debt_Additional_Infor
Long-term debt - Additional Information (Detail) (USD $) | Sep. 30, 2013 |
In Millions, unless otherwise specified | |
Debt Disclosure [Abstract] | ' |
ABL Revolver credit financing borrowing capacity | $75 |
Amount outstanding under ABL revolver | 0 |
Aggregate borrowing capacity | 38.6 |
Outstanding letters of credit | $10.90 |
Restructuring_Additional_Infor
Restructuring - Additional Information (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' |
Restructuring expenses | $66 | $714 | ($115) | $2,552 |
Restructuring costs related to the facility closure [Member] | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' |
Restructuring expenses | 66 | 714 | -115 | 2,552 |
Manchester, England Facility [Member] | Termination benefits [Member] | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' |
Restructuring expenses | ' | ' | 600 | ' |
Manchester, England Facility [Member] | Restructuring costs related to the facility closure [Member] | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' |
Restructuring expenses | ' | ' | ' | 1,400 |
Englewood, Colorado Facility [Member] | Termination benefits [Member] | ' | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' |
Restructuring expenses | $200 | ' | $200 | ' |
Restructuring_Schedule_of_Rest
Restructuring - Schedule of Restructuring Activities (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Restructuring Reserve [Roll Forward] | ' | ' | ' | ' |
Beginning balance | ' | ' | $2,119 | $340 |
Restructuring expenses | 66 | 714 | -115 | 2,552 |
Payments | ' | ' | -1,294 | -841 |
Ending balance | 710 | 2,051 | 710 | 2,051 |
Employee costs [Member] | ' | ' | ' | ' |
Restructuring Reserve [Roll Forward] | ' | ' | ' | ' |
Beginning balance | ' | ' | 1,329 | 340 |
Restructuring expenses | ' | ' | -100 | 1,577 |
Payments | ' | ' | -1,175 | -698 |
Ending balance | 54 | 1,219 | 54 | 1,219 |
Other exit costs [Member] | ' | ' | ' | ' |
Restructuring Reserve [Roll Forward] | ' | ' | ' | ' |
Beginning balance | ' | ' | 790 | 0 |
Restructuring expenses | ' | ' | -15 | 975 |
Payments | ' | ' | -119 | -143 |
Ending balance | $656 | $832 | $656 | $832 |
Divestitures_Summary_of_Operat
Divestitures - Summary of Operating Results for Discontinued Operations Prior to Disposition (Detail) (USD $) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | |
Disclosure Divestitures Summary Of Operating Results For Discontinued Operations Prior To Disposition [Abstract] | ' | ' | ' | ' | ' |
Sales | $0 | $2,501,000 | $0 | $13,745,000 | ' |
Costs and expenses | 63,000 | 7,315,000 | 63,000 | 17,399,000 | ' |
Operating income from discontinued operations | -63,000 | -4,814,000 | -63,000 | -3,654,000 | ' |
Other expenses, net | 0 | 0 | 0 | -6,000 | ' |
Income from discontinued operations before income taxes | -63,000 | -4,814,000 | -63,000 | -3,660,000 | ' |
Loss from discontinued operations, net of tax | 0 | 111,000 | 0 | 515,000 | ' |
Loss from discontinued operations, net of tax | -63,000 | -4,925,000 | -63,000 | -4,175,000 | ' |
Asset held for sale net book value | $900,000 | ' | $900,000 | ' | $1,100,000 |
Stockbased_compensation_Additi
Stock-based compensation - Additional Information (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Fully vested stock options | 4,901,107 | ' | 4,901,107 | ' |
Number of restricted stock granted to employees | 2,102,500 | 2,347,500 | 2,367,500 | 2,772,500 |
Grant date fair value (USD per share) | $0.68 | $0.79 | $0.69 | $0.79 |
Shares forfeited during period by employees | 90,500 | 125,000 | 782,000 | 857,916 |
Total unvested performance-based shares | 4,707,355 | 4,923,067 | 4,707,355 | 4,923,067 |
Total unvested time-based shares | 4,243,550 | 3,131,850 | 4,243,550 | 3,131,850 |
Stock-based compensation expense | $418,000 | $182,000 | $818,000 | $364,000 |
Non-employee stock-based compensation | 30,000 | 22,500 | 90,000 | 67,500 |
Performance Based Awards [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Vesting period, years | ' | ' | '5 years | ' |
Number of restricted stock granted to employees | 0 | 1,173,750 | 132,500 | 1,386,250 |
Total unvested shares aggregate fair values | 4,900,000 | 5,100,000 | 4,900,000 | 5,100,000 |
Time Based Options [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Vesting period, years | ' | ' | '5 years | ' |
Total unvested shares aggregate fair values | 3,400,000 | 3,000,000 | 3,400,000 | 3,000,000 |
Restricted stock awards [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Vesting period, years | ' | ' | '5 years | '5 years |
Number of restricted stock granted to employees | ' | ' | 50,000 | 837,500 |
Grant date fair value (USD per share) | ' | ' | $2.50 | $2.50 |
Vested restricted stock | ' | ' | 0 | 160,000 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | ' | ' | 60,000 | ' |
Stock-based compensation expense | 102,000 | 52,000 | 310,000 | 52,000 |
Total unvested shares of restricted stock awards aggregate fair value | $125,000 | $2,039,750 | $125,000 | $2,039,750 |
Stockbased_compensation_Activi
Stock-based compensation - Activity Relating to Roll-Over Options During Period (Detail) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Mar. 31, 2013 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | ' | ' | ' | ' |
Shares forfeited, shares | -90,500 | -125,000 | -782,000 | -857,916 | ' |
Roll-Over Shares Outstanding [Member] | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | ' | ' | ' | ' |
Balance at beginning of period, shares | ' | 80,727 | 80,727 | 201,817 | 80,727 |
Shares repurchased, shares | 0 | 0 | 0 | -67,607 | ' |
Shares exercised, shares | 0 | 0 | 0 | -33,301 | ' |
Shares forfeited, shares | 0 | 0 | 0 | -20,182 | ' |
Change in fair value, shares | 0 | 0 | 0 | 0 | ' |
Balance at end of period, shares | 80,727 | 80,727 | 80,727 | 80,727 | 80,727 |
Liability [Member] | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Liability [Roll Forward] | ' | ' | ' | ' | ' |
Balance at beginning of period, liability | ' | 141 | 141 | 355 | 141 |
Shares repurchased, liability | 0 | 0 | 0 | -119 | ' |
Shares exercised, liability | 0 | 0 | 0 | -58 | ' |
Shares forfeited, liability | 0 | 0 | 0 | -35 | ' |
Change in fair value, liability | 0 | 0 | 0 | -2 | ' |
Balance at end of period, liability | 141 | 141 | 141 | 141 | 141 |
Stockbased_compensation_Assump
Stock-based compensation - Assumptions to Determine Fair Value of Roll-over Options (Detail) | 9 Months Ended |
Sep. 30, 2013 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' |
Expected term to exercise | '6 months |
Expected volatility | 24.72% |
Risk-free rate | 0.33% |
Dividend yield | 0.00% |
Stockbased_compensation_Classi
Stock-based compensation - Classification of Stock-Based Compensation (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Stock-based compensation expense | $418 | $182 | $818 | $364 |
Cost of sales | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Stock-based compensation expense | 158 | 43 | 269 | 81 |
Selling, general and administrative | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Stock-based compensation expense | $260 | $139 | $549 | $283 |
Stockbased_compensation_StockB
Stock-based compensation - Stock-Based Compensation by Type of Award (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Stock-based compensation expense | $418 | $182 | $818 | $364 |
Time-based vesting options [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Stock-based compensation expense | 316 | 130 | 508 | 314 |
Restricted stock awards [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Stock-based compensation expense | 102 | 52 | 310 | 52 |
Roll-Over Shares Outstanding [Member] | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' |
Stock-based compensation expense | $0 | $0 | $0 | ($2) |
Income_taxes_Additional_Inform
Income taxes - Additional Information (Detail) (USD $) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | |
Income Tax Disclosure [Abstract] | ' | ' | ' | ' | ' |
Provision for income taxes | $1,035,000 | $999,000 | $3,158,000 | $2,717,000 | ' |
Deferred income tax expense for differences in the book and tax treatment of goodwill | ' | 700,000 | 1,785,000 | 2,099,000 | ' |
Deferred income taxes related to Goodwill | 700,000 | ' | 2,000,000 | ' | ' |
Other taxes | 300,000 | ' | 1,200,000 | ' | ' |
State and foreign income tax expense | ' | 300,000 | ' | 600,000 | ' |
Net deferred tax assets | $31,900,000 | ' | $31,900,000 | ' | $29,900,000 |
Related_party_transactions_Add
Related party transactions - Additional Information (Detail) (USD $) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 | |
KKR | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Management fees and related expenses | $351,000 | $335,000 | $1,055,000 | $1,005,000 | ' |
Unpaid management fees | 300,000 | ' | 300,000 | ' | 400,000 |
KKR-Capstone | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Management fees and related expenses | 0 | 0 | 0 | 0 | ' |
Unpaid management fees | 0 | ' | 0 | ' | 300,000 |
KKR-AM | Senior Secured Notes | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Senior secured notes | 14,000,000 | ' | 14,000,000 | ' | 14,700,000 |
KKR-AM | 2017 Subordinated Notes | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Senior secured notes | 23,400,000 | ' | 23,400,000 | ' | 23,400,000 |
Biomet, Inc. | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Net sales resulting from product shipments | 100,000 | 100,000 | 100,000 | 300,000 | ' |
Receivables from related party | ' | ' | ' | ' | 100,000 |
SunGard | ' | ' | ' | ' | ' |
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
Information systems service cost | 200,000 | 200,000 | 600,000 | 600,000 | ' |
Amount due to related party | $100,000 | ' | $100,000 | ' | $100,000 |
Fair_value_measurements_Summar
Fair value measurements - Summary of Financial Assets and Liabilities Recorded at Fair Value (Detail) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment in Available for Sale Security | ' | $210 |
Liability for Roll-Over options | 141 | 141 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment in Available for Sale Security | ' | 210 |
Liability for Roll-Over options | 0 | 0 |
Significant Other Observable Inputs (Level 2) | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment in Available for Sale Security | ' | 0 |
Liability for Roll-Over options | 0 | 0 |
Significant Unobservable Inputs (Level 3) | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment in Available for Sale Security | ' | 0 |
Liability for Roll-Over options | $141 | $141 |
Fair_value_measurements_Additi
Fair value measurements - Additional Information (Detail) (USD $) | 9 Months Ended | |||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Dec. 31, 2012 |
Senior Secured Notes Due 2017 | Senior Subordinated Notes Due 2017 | Carrying (Reported) Amount, Fair Value Disclosure [Member] | ||
Fair Value, Measurements, Nonrecurring [Member] | ||||
Significant Other Observable Inputs (Level 2) | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ' | ' |
Percentage over carrying value | ' | 104.90% | 92.40% | ' |
Fair value | ' | $419.60 | $291.10 | ' |
Carrying value | ' | 400 | 315 | ' |
Assets held for sale | ' | ' | ' | 1.1 |
Write down of asset held for sale | $0.20 | ' | ' | ' |
Environmental_matters_Addition
Environmental matters - Additional Information (Detail) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Millions, unless otherwise specified | industry_sector | |
Environmental Remediation Obligations [Abstract] | ' | ' |
Number of industry sectors exempted | 3 | ' |
Reserves for environmental liabilities | $1.40 | $1.60 |
Expected environmental payment | $0.10 | ' |
Supplemental_guarantor_condens2
Supplemental guarantor condensed consolidating financial statements - Unaudited Condensed Consolidating Statements of Operations (Detail) (USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Net sales | $135,437 | ' | ' | $125,961 | $386,968 | $376,526 | ' |
Cost of sales (exclusive of amortization) | 97,561 | ' | ' | 92,250 | 287,819 | 280,370 | ' |
Selling, general and administrative expenses | 12,511 | ' | ' | 12,833 | 39,536 | 41,502 | ' |
Research and development expenses | 508 | ' | ' | 419 | 1,507 | 1,364 | ' |
Impairment of goodwill | 0 | 12,100 | 51,000 | 0 | 63,128 | 0 | 0 |
Restructuring expenses | 66 | ' | ' | 714 | -115 | 2,552 | ' |
Amortization of intangible assets | 3,735 | ' | ' | 3,735 | 11,205 | 11,205 | ' |
Gain (loss) on disposal of assets | 204 | ' | ' | -221 | 896 | -254 | ' |
Income (loss) from continuing operations | 20,852 | ' | ' | 16,231 | -17,008 | 39,787 | ' |
Interest (expense) income, net | -17,288 | ' | ' | -17,379 | -51,865 | -51,879 | ' |
Other (expense) income, net | -103 | ' | ' | 592 | -283 | -90 | ' |
(Loss) income from continuing operations before income taxes | 3,461 | ' | ' | -556 | -69,156 | -12,182 | ' |
Provision for income taxes | 1,035 | ' | ' | 999 | 3,158 | 2,717 | ' |
Net (loss) income from continuing operations | 2,426 | ' | ' | -1,555 | -72,314 | -14,899 | ' |
Less net income from discontinued operations, net of tax | -63 | ' | ' | -4,925 | -63 | -4,175 | ' |
Net (loss) income | 2,363 | ' | ' | -6,480 | -72,377 | -19,074 | ' |
Parent | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Net sales | 0 | ' | ' | 0 | 0 | 0 | ' |
Cost of sales (exclusive of amortization) | 0 | ' | ' | 0 | 0 | 0 | ' |
Selling, general and administrative expenses | 30 | ' | ' | 23 | 92 | 69 | ' |
Research and development expenses | 0 | ' | ' | 0 | 0 | 0 | ' |
Impairment of goodwill | 0 | ' | ' | ' | 63,128 | ' | ' |
Restructuring expenses | 0 | ' | ' | 0 | 0 | 0 | ' |
Amortization of intangible assets | 3,735 | ' | ' | 3,735 | 11,205 | 11,205 | ' |
Gain (loss) on disposal of assets | 0 | ' | ' | 0 | 0 | 0 | ' |
Income (loss) from continuing operations | -3,765 | ' | ' | -3,758 | -74,425 | -11,274 | ' |
Interest (expense) income, net | -17,287 | ' | ' | -17,363 | -51,867 | -51,812 | ' |
Other (expense) income, net | 0 | ' | ' | 0 | 923 | 0 | ' |
Equity in earnings (losses) of affiliates | 23,415 | ' | ' | 19,772 | 52,992 | 49,143 | ' |
(Loss) income from continuing operations before income taxes | 2,363 | ' | ' | -1,349 | -72,377 | -13,943 | ' |
Provision for income taxes | 0 | ' | ' | 0 | 0 | 0 | ' |
Net (loss) income from continuing operations | 2,363 | ' | ' | -1,349 | -72,377 | -13,943 | ' |
Less net income from discontinued operations, net of tax | 0 | ' | ' | -5,131 | 0 | -5,131 | ' |
Net (loss) income | 2,363 | ' | ' | -6,480 | -72,377 | -19,074 | ' |
Subsidiary Guarantors | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Net sales | 123,983 | ' | ' | 115,587 | 355,194 | 346,842 | ' |
Cost of sales (exclusive of amortization) | 89,848 | ' | ' | 85,095 | 265,785 | 260,184 | ' |
Selling, general and administrative expenses | 11,594 | ' | ' | 11,918 | 36,746 | 38,702 | ' |
Research and development expenses | 294 | ' | ' | 210 | 919 | 707 | ' |
Impairment of goodwill | 0 | ' | ' | ' | 0 | ' | ' |
Restructuring expenses | 66 | ' | ' | 714 | -115 | 2,552 | ' |
Amortization of intangible assets | 0 | ' | ' | 0 | 0 | 0 | ' |
Gain (loss) on disposal of assets | 148 | ' | ' | -223 | 814 | -264 | ' |
Income (loss) from continuing operations | 22,033 | ' | ' | 17,873 | 51,045 | 44,961 | ' |
Interest (expense) income, net | 715 | ' | ' | 656 | 2,123 | 1,997 | ' |
Other (expense) income, net | 1,160 | ' | ' | 167 | 306 | -1,154 | ' |
Equity in earnings (losses) of affiliates | 202 | ' | ' | 1,313 | 1,649 | 3,273 | ' |
(Loss) income from continuing operations before income taxes | 24,110 | ' | ' | 20,009 | 55,123 | 49,077 | ' |
Provision for income taxes | 632 | ' | ' | 443 | 2,068 | 890 | ' |
Net (loss) income from continuing operations | 23,478 | ' | ' | 19,566 | 53,055 | 48,187 | ' |
Less net income from discontinued operations, net of tax | -63 | ' | ' | 206 | -63 | 956 | ' |
Net (loss) income | 23,415 | ' | ' | 19,772 | 52,992 | 49,143 | ' |
Non-Guarantor Subsidiaries | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Net sales | 11,864 | ' | ' | 10,939 | 32,827 | 31,397 | ' |
Cost of sales (exclusive of amortization) | 8,123 | ' | ' | 7,720 | 23,087 | 21,899 | ' |
Selling, general and administrative expenses | 887 | ' | ' | 892 | 2,698 | 2,731 | ' |
Research and development expenses | 214 | ' | ' | 209 | 588 | 657 | ' |
Impairment of goodwill | 0 | ' | ' | ' | 0 | ' | ' |
Restructuring expenses | 0 | ' | ' | 0 | 0 | 0 | ' |
Amortization of intangible assets | 0 | ' | ' | 0 | 0 | 0 | ' |
Gain (loss) on disposal of assets | 56 | ' | ' | 2 | 82 | 10 | ' |
Income (loss) from continuing operations | 2,584 | ' | ' | 2,116 | 6,372 | 6,100 | ' |
Interest (expense) income, net | -716 | ' | ' | -672 | -2,121 | -2,064 | ' |
Other (expense) income, net | -1,263 | ' | ' | 425 | -1,512 | 1,064 | ' |
Equity in earnings (losses) of affiliates | 0 | ' | ' | 0 | 0 | 0 | ' |
(Loss) income from continuing operations before income taxes | 605 | ' | ' | 1,869 | 2,739 | 5,100 | ' |
Provision for income taxes | 403 | ' | ' | 556 | 1,090 | 1,827 | ' |
Net (loss) income from continuing operations | 202 | ' | ' | 1,313 | 1,649 | 3,273 | ' |
Less net income from discontinued operations, net of tax | 0 | ' | ' | 0 | 0 | 0 | ' |
Net (loss) income | 202 | ' | ' | 1,313 | 1,649 | 3,273 | ' |
Eliminations | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Net sales | -410 | ' | ' | -565 | -1,053 | -1,713 | ' |
Cost of sales (exclusive of amortization) | -410 | ' | ' | -565 | -1,053 | -1,713 | ' |
Selling, general and administrative expenses | 0 | ' | ' | 0 | 0 | 0 | ' |
Research and development expenses | 0 | ' | ' | 0 | 0 | 0 | ' |
Impairment of goodwill | 0 | ' | ' | ' | 0 | ' | ' |
Restructuring expenses | 0 | ' | ' | 0 | 0 | 0 | ' |
Amortization of intangible assets | 0 | ' | ' | 0 | 0 | 0 | ' |
Gain (loss) on disposal of assets | 0 | ' | ' | 0 | 0 | 0 | ' |
Income (loss) from continuing operations | 0 | ' | ' | 0 | 0 | 0 | ' |
Interest (expense) income, net | 0 | ' | ' | 0 | 0 | 0 | ' |
Other (expense) income, net | 0 | ' | ' | 0 | 0 | 0 | ' |
Equity in earnings (losses) of affiliates | -23,617 | ' | ' | -21,085 | -54,641 | -52,416 | ' |
(Loss) income from continuing operations before income taxes | -23,617 | ' | ' | -21,085 | -54,641 | -52,416 | ' |
Provision for income taxes | 0 | ' | ' | 0 | 0 | 0 | ' |
Net (loss) income from continuing operations | -23,617 | ' | ' | -21,085 | -54,641 | -52,416 | ' |
Less net income from discontinued operations, net of tax | 0 | ' | ' | 0 | 0 | 0 | ' |
Net (loss) income | -23,617 | ' | ' | -21,085 | -54,641 | -52,416 | ' |
Consolidated | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Net sales | 135,437 | ' | ' | 125,961 | 386,968 | 376,526 | ' |
Cost of sales (exclusive of amortization) | 97,561 | ' | ' | 92,250 | 287,819 | 280,370 | ' |
Selling, general and administrative expenses | 12,511 | ' | ' | 12,833 | 39,536 | 41,502 | ' |
Research and development expenses | 508 | ' | ' | 419 | 1,507 | 1,364 | ' |
Impairment of goodwill | 0 | ' | ' | ' | 63,128 | ' | ' |
Restructuring expenses | 66 | ' | ' | 714 | -115 | 2,552 | ' |
Amortization of intangible assets | 3,735 | ' | ' | 3,735 | 11,205 | 11,205 | ' |
Gain (loss) on disposal of assets | 204 | ' | ' | -221 | 896 | -254 | ' |
Income (loss) from continuing operations | 20,852 | ' | ' | 16,231 | -17,008 | 39,787 | ' |
Interest (expense) income, net | -17,288 | ' | ' | -17,379 | -51,865 | -51,879 | ' |
Other (expense) income, net | -103 | ' | ' | 592 | -283 | -90 | ' |
Equity in earnings (losses) of affiliates | 0 | ' | ' | 0 | 0 | 0 | ' |
(Loss) income from continuing operations before income taxes | 3,461 | ' | ' | -556 | -69,156 | -12,182 | ' |
Provision for income taxes | 1,035 | ' | ' | 999 | 3,158 | 2,717 | ' |
Net (loss) income from continuing operations | 2,426 | ' | ' | -1,555 | -72,314 | -14,899 | ' |
Less net income from discontinued operations, net of tax | -63 | ' | ' | -4,925 | -63 | -4,175 | ' |
Net (loss) income | $2,363 | ' | ' | ($6,480) | ($72,377) | ($19,074) | ' |
Supplemental_guarantor_condens3
Supplemental guarantor condensed consolidating financial statements - Unaudited Condensed Consolidating Balance Sheets (Detail) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Dec. 31, 2011 |
In Thousands, unless otherwise specified | ||||
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Cash | $64,577 | $59,902 | $49,587 | $38,858 |
Accounts receivable, net | 56,735 | 49,403 | ' | ' |
Inventories | 63,329 | 57,069 | ' | ' |
Prepaid expenses and other current assets | 3,403 | 10,973 | ' | ' |
Total current assets | 188,044 | 177,347 | ' | ' |
Property, plant and equipment, net | 116,315 | 114,809 | ' | ' |
Assets held for sale | 880 | 1,060 | ' | ' |
Goodwill | 556,315 | 619,443 | ' | ' |
Other intangible assets, net | 123,543 | 134,747 | ' | ' |
Deferred financing costs and other assets, net | 11,634 | 13,766 | ' | ' |
Total assets | 996,731 | 1,061,172 | ' | ' |
Current portion of long-term debt | 7 | 11 | ' | ' |
Accounts payable | 22,259 | 20,044 | ' | ' |
Accrued expenses and other current liabilities | 15,915 | 17,359 | ' | ' |
Total current liabilities | 68,751 | 63,566 | ' | ' |
Long-term debt | 713,560 | 713,294 | ' | ' |
Other long-term liabilities | 40,984 | 39,905 | ' | ' |
Total liabilities | 823,295 | 816,765 | ' | ' |
Equity | 173,436 | 244,407 | ' | ' |
Total liabilities and stockholders’ equity | 996,731 | 1,061,172 | ' | ' |
Parent | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Cash | 0 | 0 | 0 | 0 |
Accounts receivable, net | 0 | 0 | ' | ' |
Inventories | 0 | 0 | ' | ' |
Prepaid expenses and other current assets | 24 | 215 | ' | ' |
Total current assets | 24 | 215 | ' | ' |
Property, plant and equipment, net | 0 | 0 | ' | ' |
Assets held for sale | 0 | 0 | ' | ' |
Intercompany receivables, net | 0 | 0 | ' | ' |
Investment in subsidiaries | 608,507 | 554,794 | ' | ' |
Goodwill | 556,315 | 619,443 | ' | ' |
Other intangible assets, net | 123,543 | 134,747 | ' | ' |
Deferred financing costs and other assets, net | 11,090 | 13,269 | ' | ' |
Total assets | 1,299,479 | 1,322,468 | ' | ' |
Current portion of long-term debt | 0 | 0 | ' | ' |
Accounts payable | 0 | 1 | ' | ' |
Accrued expenses and other current liabilities | 18,804 | 19,317 | ' | ' |
Total current liabilities | 18,804 | 19,318 | ' | ' |
Long-term debt | 1,106,313 | 1,057,832 | ' | ' |
Other long-term liabilities | 926 | 911 | ' | ' |
Total liabilities | 1,126,043 | 1,078,061 | ' | ' |
Equity | 173,436 | 244,407 | ' | ' |
Total liabilities and stockholders’ equity | 1,299,479 | 1,322,468 | ' | ' |
Subsidiary Guarantors | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Cash | 56,651 | 53,812 | 44,550 | 32,627 |
Accounts receivable, net | 52,603 | 46,992 | ' | ' |
Inventories | 58,232 | 52,807 | ' | ' |
Prepaid expenses and other current assets | 3,095 | 10,399 | ' | ' |
Total current assets | 170,581 | 164,010 | ' | ' |
Property, plant and equipment, net | 87,721 | 89,413 | ' | ' |
Assets held for sale | 880 | 1,060 | ' | ' |
Intercompany receivables, net | 417,205 | 365,713 | ' | ' |
Investment in subsidiaries | 11,523 | 9,143 | ' | ' |
Goodwill | 0 | 0 | ' | ' |
Other intangible assets, net | 0 | 0 | ' | ' |
Deferred financing costs and other assets, net | 64 | -8 | ' | ' |
Total assets | 687,974 | 629,331 | ' | ' |
Current portion of long-term debt | 7 | 11 | ' | ' |
Accounts payable | 20,845 | 18,613 | ' | ' |
Accrued expenses and other current liabilities | 22,098 | 20,267 | ' | ' |
Total current liabilities | 42,950 | 38,891 | ' | ' |
Long-term debt | 0 | 0 | ' | ' |
Other long-term liabilities | 36,517 | 35,646 | ' | ' |
Total liabilities | 79,467 | 74,537 | ' | ' |
Equity | 608,507 | 554,794 | ' | ' |
Total liabilities and stockholders’ equity | 687,974 | 629,331 | ' | ' |
Non-Guarantor Subsidiaries | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Cash | 7,926 | 6,090 | 5,037 | 6,231 |
Accounts receivable, net | 4,559 | 2,929 | ' | ' |
Inventories | 5,097 | 4,262 | ' | ' |
Prepaid expenses and other current assets | 284 | 359 | ' | ' |
Total current assets | 17,866 | 13,640 | ' | ' |
Property, plant and equipment, net | 28,594 | 25,396 | ' | ' |
Assets held for sale | 0 | 0 | ' | ' |
Intercompany receivables, net | 0 | 0 | ' | ' |
Investment in subsidiaries | 0 | 0 | ' | ' |
Goodwill | 0 | 0 | ' | ' |
Other intangible assets, net | 0 | 0 | ' | ' |
Deferred financing costs and other assets, net | 480 | 505 | ' | ' |
Total assets | 46,940 | 39,541 | ' | ' |
Current portion of long-term debt | 0 | 0 | ' | ' |
Accounts payable | 1,841 | 1,948 | ' | ' |
Accrued expenses and other current liabilities | 5,583 | 3,927 | ' | ' |
Total current liabilities | 7,424 | 5,875 | ' | ' |
Long-term debt | 24,452 | 21,175 | ' | ' |
Other long-term liabilities | 3,541 | 3,348 | ' | ' |
Total liabilities | 35,417 | 30,398 | ' | ' |
Equity | 11,523 | 9,143 | ' | ' |
Total liabilities and stockholders’ equity | 46,940 | 39,541 | ' | ' |
Eliminations | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Cash | 0 | 0 | 0 | 0 |
Accounts receivable, net | -427 | -518 | ' | ' |
Inventories | 0 | 0 | ' | ' |
Prepaid expenses and other current assets | 0 | 0 | ' | ' |
Total current assets | -427 | -518 | ' | ' |
Property, plant and equipment, net | 0 | 0 | ' | ' |
Assets held for sale | 0 | 0 | ' | ' |
Intercompany receivables, net | -417,205 | -365,713 | ' | ' |
Investment in subsidiaries | -620,030 | -563,937 | ' | ' |
Goodwill | 0 | 0 | ' | ' |
Other intangible assets, net | 0 | 0 | ' | ' |
Deferred financing costs and other assets, net | 0 | 0 | ' | ' |
Total assets | -1,037,662 | -930,168 | ' | ' |
Current portion of long-term debt | 0 | 0 | ' | ' |
Accounts payable | -427 | -518 | ' | ' |
Accrued expenses and other current liabilities | 0 | 0 | ' | ' |
Total current liabilities | -427 | -518 | ' | ' |
Long-term debt | -417,205 | -365,713 | ' | ' |
Other long-term liabilities | 0 | 0 | ' | ' |
Total liabilities | -417,632 | -366,231 | ' | ' |
Equity | -620,030 | -563,937 | ' | ' |
Total liabilities and stockholders’ equity | -1,037,662 | -930,168 | ' | ' |
Consolidated | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Cash | 64,577 | 59,902 | 49,587 | 38,858 |
Accounts receivable, net | 56,735 | 49,403 | ' | ' |
Inventories | 63,329 | 57,069 | ' | ' |
Prepaid expenses and other current assets | 3,403 | 10,973 | ' | ' |
Total current assets | 188,044 | 177,347 | ' | ' |
Property, plant and equipment, net | 116,315 | 114,809 | ' | ' |
Assets held for sale | 880 | 1,060 | ' | ' |
Intercompany receivables, net | 0 | 0 | ' | ' |
Investment in subsidiaries | 0 | 0 | ' | ' |
Goodwill | 556,315 | 619,443 | ' | ' |
Other intangible assets, net | 123,543 | 134,747 | ' | ' |
Deferred financing costs and other assets, net | 11,634 | 13,766 | ' | ' |
Total assets | 996,731 | 1,061,172 | ' | ' |
Current portion of long-term debt | 7 | 11 | ' | ' |
Accounts payable | 22,259 | 20,044 | ' | ' |
Accrued expenses and other current liabilities | 46,485 | 43,511 | ' | ' |
Total current liabilities | 68,751 | 63,566 | ' | ' |
Long-term debt | 713,560 | 713,294 | ' | ' |
Other long-term liabilities | 40,984 | 39,905 | ' | ' |
Total liabilities | 823,295 | 816,765 | ' | ' |
Equity | 173,436 | 244,407 | ' | ' |
Total liabilities and stockholders’ equity | $996,731 | $1,061,172 | ' | ' |
Supplemental_guarantor_condens4
Supplemental guarantor condensed consolidating financial statements - Unaudited Condensed Consolidating Statements of Comprehensive Income (Loss) (Detail) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net income (loss) | $2,363 | ($6,480) | ($72,377) | ($19,074) |
Unrealized gain on available for sale security | 0 | -250 | 32 | -57 |
Realized gain on available for sale security | 0 | 0 | -242 | 0 |
Cumulative translation adjustment | ' | ' | 723 | ' |
Comprehensive (loss) income | 3,018 | -6,386 | -71,864 | -18,773 |
Parent | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net income (loss) | 2,363 | -6,480 | -72,377 | -19,074 |
Unrealized gain on available for sale security | ' | -250 | 32 | -57 |
Realized gain on available for sale security | ' | ' | -242 | ' |
Cumulative translation adjustment | 655 | 344 | 723 | 358 |
Comprehensive (loss) income | 3,018 | -6,386 | -71,864 | -18,773 |
Subsidiary Guarantors | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net income (loss) | 23,415 | 19,772 | 52,992 | 49,143 |
Unrealized gain on available for sale security | ' | 0 | 0 | 0 |
Realized gain on available for sale security | ' | ' | 0 | ' |
Cumulative translation adjustment | 269 | 163 | -8 | 218 |
Comprehensive (loss) income | 23,684 | 19,935 | 52,984 | 49,361 |
Non-Guarantor Subsidiaries | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net income (loss) | 202 | 1,313 | 1,649 | 3,273 |
Unrealized gain on available for sale security | ' | 0 | 0 | 0 |
Realized gain on available for sale security | ' | ' | 0 | ' |
Cumulative translation adjustment | 386 | 181 | 731 | 140 |
Comprehensive (loss) income | 588 | 1,494 | 2,380 | 3,413 |
Eliminations | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net income (loss) | -23,617 | -21,085 | -54,641 | -52,416 |
Unrealized gain on available for sale security | ' | 0 | 0 | 0 |
Realized gain on available for sale security | ' | ' | 0 | ' |
Cumulative translation adjustment | -655 | -344 | -723 | -358 |
Comprehensive (loss) income | -24,272 | -21,429 | -55,364 | -52,774 |
Consolidated | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net income (loss) | 2,363 | -6,480 | -72,377 | -19,074 |
Unrealized gain on available for sale security | ' | -250 | 32 | -57 |
Realized gain on available for sale security | ' | ' | -242 | ' |
Cumulative translation adjustment | 655 | 344 | 723 | 358 |
Comprehensive (loss) income | $3,018 | ($6,386) | ($71,864) | ($18,773) |
Supplemental_guarantor_condens5
Supplemental guarantor condensed consolidating financial statements - Unaudited Condensed Consolidating Statements of Cash Flows (Detail) (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Segment Reporting Information [Line Items] | ' | ' |
Net cash (used in) provided by operating activities of continuing operations | $12,617 | $13,746 |
Net cash provided by (used in) operating activities of discontinued operations | -265 | 2,406 |
Net cash provided by operating activities | 12,352 | 16,152 |
Capital expenditures | -16,193 | -13,180 |
Proceeds from disposition of assets | 68 | 264 |
Proceeds from the sale of available for sale securities | 242 | 0 |
Net cash used in investing activities of continuing operations | -15,883 | -12,916 |
Net cash used in investing activities of discontinued operations | 7,987 | 7,484 |
Net cash used in investing activities | -7,896 | -5,432 |
Repayments of long-term debt and capital lease obligations | -9 | -16 |
Net cash used in financing activities | -9 | -59 |
Effect of exchange rate changes in cash | 228 | 68 |
Net increase in cash | 4,675 | 10,729 |
Cash, beginning of period | 59,902 | 38,858 |
Cash, end of period | 64,577 | 49,587 |
Parent | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Net cash (used in) provided by operating activities of continuing operations | -48,325 | -49,930 |
Net cash provided by (used in) operating activities of discontinued operations | 0 | 0 |
Net cash provided by operating activities | -48,325 | -49,930 |
Capital expenditures | 0 | 0 |
Proceeds from disposition of assets | 0 | 0 |
Proceeds from the sale of available for sale securities | 242 | ' |
Net cash used in investing activities of continuing operations | 242 | 0 |
Net cash used in investing activities of discontinued operations | 0 | 0 |
Net cash used in investing activities | 242 | 0 |
Repayments of long-term debt and capital lease obligations | 0 | 0 |
Intercompany receipts (advances) | 48,083 | 49,973 |
Proceeds from (repurchase of) sale of parent company stock | ' | -43 |
Net cash used in financing activities | 48,083 | 49,930 |
Effect of exchange rate changes in cash | 0 | 0 |
Net increase in cash | 0 | 0 |
Cash, beginning of period | 0 | 0 |
Cash, end of period | 0 | 0 |
Subsidiary Guarantors | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Net cash (used in) provided by operating activities of continuing operations | 56,307 | 59,628 |
Net cash provided by (used in) operating activities of discontinued operations | -265 | 2,406 |
Net cash provided by operating activities | 56,042 | 62,034 |
Capital expenditures | -9,877 | -4,552 |
Proceeds from disposition of assets | 61 | 264 |
Proceeds from the sale of available for sale securities | 0 | ' |
Net cash used in investing activities of continuing operations | -9,816 | -4,288 |
Net cash used in investing activities of discontinued operations | 7,987 | 7,484 |
Net cash used in investing activities | -1,829 | 3,196 |
Repayments of long-term debt and capital lease obligations | -9 | -14 |
Intercompany receipts (advances) | -51,357 | -53,379 |
Proceeds from (repurchase of) sale of parent company stock | ' | 0 |
Net cash used in financing activities | -51,366 | -53,393 |
Effect of exchange rate changes in cash | -8 | 86 |
Net increase in cash | 2,839 | 11,923 |
Cash, beginning of period | 53,812 | 32,627 |
Cash, end of period | 56,651 | 44,550 |
Non-Guarantor Subsidiaries | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Net cash (used in) provided by operating activities of continuing operations | 4,635 | 4,048 |
Net cash provided by (used in) operating activities of discontinued operations | 0 | 0 |
Net cash provided by operating activities | 4,635 | 4,048 |
Capital expenditures | -6,316 | -8,628 |
Proceeds from disposition of assets | 7 | 0 |
Proceeds from the sale of available for sale securities | 0 | ' |
Net cash used in investing activities of continuing operations | -6,309 | -8,628 |
Net cash used in investing activities of discontinued operations | 0 | 0 |
Net cash used in investing activities | -6,309 | -8,628 |
Repayments of long-term debt and capital lease obligations | 0 | -2 |
Intercompany receipts (advances) | 3,274 | 3,406 |
Proceeds from (repurchase of) sale of parent company stock | ' | 0 |
Net cash used in financing activities | 3,274 | 3,404 |
Effect of exchange rate changes in cash | 236 | -18 |
Net increase in cash | 1,836 | -1,194 |
Cash, beginning of period | 6,090 | 6,231 |
Cash, end of period | 7,926 | 5,037 |
Eliminations | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Net cash (used in) provided by operating activities of continuing operations | 0 | 0 |
Net cash provided by (used in) operating activities of discontinued operations | 0 | 0 |
Net cash provided by operating activities | 0 | 0 |
Capital expenditures | 0 | 0 |
Proceeds from disposition of assets | 0 | 0 |
Proceeds from the sale of available for sale securities | 0 | ' |
Net cash used in investing activities of continuing operations | 0 | 0 |
Net cash used in investing activities of discontinued operations | 0 | 0 |
Net cash used in investing activities | 0 | 0 |
Repayments of long-term debt and capital lease obligations | 0 | 0 |
Intercompany receipts (advances) | 0 | 0 |
Proceeds from (repurchase of) sale of parent company stock | ' | 0 |
Net cash used in financing activities | 0 | 0 |
Effect of exchange rate changes in cash | 0 | 0 |
Net increase in cash | 0 | 0 |
Cash, beginning of period | 0 | 0 |
Cash, end of period | 0 | 0 |
Consolidated | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Net cash (used in) provided by operating activities of continuing operations | 12,617 | 13,746 |
Net cash provided by (used in) operating activities of discontinued operations | -265 | 2,406 |
Net cash provided by operating activities | 12,352 | 16,152 |
Capital expenditures | -16,193 | -13,180 |
Proceeds from disposition of assets | 68 | 264 |
Proceeds from the sale of available for sale securities | 242 | ' |
Net cash used in investing activities of continuing operations | -15,883 | -12,916 |
Net cash used in investing activities of discontinued operations | 7,987 | 7,484 |
Net cash used in investing activities | -7,896 | -5,432 |
Repayments of long-term debt and capital lease obligations | -9 | -16 |
Intercompany receipts (advances) | 0 | 0 |
Proceeds from (repurchase of) sale of parent company stock | ' | -43 |
Net cash used in financing activities | -9 | -59 |
Effect of exchange rate changes in cash | 228 | 68 |
Net increase in cash | 4,675 | 10,729 |
Cash, beginning of period | 59,902 | 38,858 |
Cash, end of period | $64,577 | $49,587 |
Changes_in_Stockholders_Equity2
Changes in Stockholders' Equity - Summary of Changes in Stockholders' Equity (Detail) (USD $) | 3 Months Ended | 9 Months Ended | 9 Months Ended | ||||||
In Thousands, except Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 |
Common Stock [Member] | Common Stock [Member] | Additional paid-in capital [Member] | Accumulated other comprehensive income [Member] | Accumulated (deficit) [Member] | |||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Balance | ' | ' | $244,407 | ' | $0 | $0 | $639,610 | ($2,554) | ($392,649) |
Balance, shares | ' | ' | ' | ' | 1,000 | 1,000 | ' | ' | ' |
Net (loss) income | 2,363 | -6,480 | -72,377 | -19,074 | ' | ' | ' | ' | -72,377 |
Unrealized gain on available for sale security | 0 | -250 | 32 | -57 | ' | ' | ' | 32 | ' |
Realized gain on available for sale security | 0 | 0 | -242 | 0 | ' | ' | ' | -242 | ' |
Cumulative translation adjustment | ' | ' | 723 | ' | ' | ' | ' | 723 | ' |
Comprehensive (loss) income | 3,018 | -6,386 | -71,864 | -18,773 | ' | ' | ' | ' | ' |
Stock-based compensation and other | ' | ' | 893 | ' | ' | ' | 893 | ' | ' |
Balance | $173,436 | ' | $173,436 | ' | $0 | $0 | $640,503 | ($2,041) | ($465,026) |
Balance, shares | ' | ' | ' | ' | 1,000 | 1,000 | ' | ' | ' |
Changes_in_Accumulated_Other_C2
Changes in Accumulated Other Comprehensive Loss - Summary of Changes (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ' | ' | ' | ' |
Beginning Balance | ($2,696) | ($1,059) | ($2,554) | ($1,266) |
Other comprehensive income before reclassifications | 655 | 94 | 513 | 301 |
Amounts reclassified from accumulated other comprehensive income | 0 | 0 | 0 | 0 |
Net current-period other comprehensive income | 655 | 94 | 513 | 301 |
Ending Balance | -2,041 | -965 | -2,041 | -965 |
Defined Benefit Pension Items | ' | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ' | ' | ' | ' |
Beginning Balance | -1,159 | -317 | -1,159 | -317 |
Other comprehensive income before reclassifications | 0 | 0 | 0 | 0 |
Amounts reclassified from accumulated other comprehensive income | 0 | 0 | 0 | 0 |
Net current-period other comprehensive income | 0 | 0 | 0 | 0 |
Ending Balance | -1,159 | -317 | -1,159 | -317 |
Unrealized Gains and Losses on Available-for-Sale Securities | ' | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ' | ' | ' | ' |
Beginning Balance | 0 | 1,348 | 210 | 1,155 |
Other comprehensive income before reclassifications | 0 | -250 | -210 | -57 |
Amounts reclassified from accumulated other comprehensive income | 0 | 0 | 0 | 0 |
Net current-period other comprehensive income | 0 | -250 | -210 | -57 |
Ending Balance | 0 | 1,098 | 0 | 1,098 |
Foreign Currency Items | ' | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ' | ' | ' | ' |
Beginning Balance | -1,537 | -2,090 | -1,605 | -2,104 |
Other comprehensive income before reclassifications | 655 | 344 | 723 | 358 |
Amounts reclassified from accumulated other comprehensive income | 0 | 0 | 0 | 0 |
Net current-period other comprehensive income | 655 | 344 | 723 | 358 |
Ending Balance | ($882) | ($1,746) | ($882) | ($1,746) |
Segment_Information_Additional
Segment Information - Additional Information (Details) | 3 Months Ended | 9 Months Ended |
Mar. 31, 2013 | Sep. 30, 2013 | |
segment | segment | |
Segment Reporting [Abstract] | ' | ' |
Number of reportable segments | 2 | 2 |
Segment_Information_Schedule_o
Segment Information - Schedule of Segment Income (Loss) from Operations (Details) (USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Dec. 31, 2012 |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Revenue | $135,437 | ' | ' | $125,961 | $386,968 | $376,526 | ' |
Adjusted EBITDA | 30,584 | ' | ' | 28,152 | 76,637 | 75,944 | ' |
Impairment of goodwill | 0 | -12,100 | -51,000 | 0 | -63,128 | 0 | 0 |
Interest expense, net | -17,288 | ' | ' | -17,379 | -51,865 | -51,879 | ' |
Depreciation and amortization | -8,406 | ' | ' | -10,090 | -24,634 | -29,578 | ' |
Stock-based compensation | ' | ' | ' | ' | -908 | -432 | ' |
Restructuring | -66 | ' | ' | -714 | 115 | -2,552 | ' |
Currency gain/loss | -111 | ' | ' | 568 | -1,231 | -152 | ' |
Gain on disposal of property and equipment | -204 | ' | ' | 221 | -896 | 254 | ' |
Other taxes | -70 | ' | ' | -80 | -218 | -395 | ' |
Proceeds from the sale of available for sale securities | 0 | ' | ' | 0 | 242 | 0 | ' |
Total adjustments | -27,123 | ' | ' | -28,708 | -145,793 | -88,126 | ' |
(Loss) income from continuing operations before income taxes | 3,461 | ' | ' | -556 | -69,156 | -12,182 | ' |
KKR | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Management fees to stockholder | -351 | ' | ' | -335 | -1,055 | -1,005 | ' |
Employee Severance and Relocation [Member] | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructuring | -152 | ' | ' | -500 | -971 | -1,870 | ' |
Facility Closing [Member] | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructuring | -66 | ' | ' | -714 | 115 | -2,552 | ' |
Other Restructuring [Member] | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Restructuring | -27 | ' | ' | -194 | -1,244 | -517 | ' |
Employee [Member] | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Stock-based compensation | -418 | ' | ' | -182 | -818 | -364 | ' |
Non-employee [Member] | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Stock-based compensation | -30 | ' | ' | -23 | -90 | -68 | ' |
Cardio and Vascular [Member] | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Revenue | 83,337 | ' | ' | 79,550 | 240,505 | 236,235 | ' |
Adjusted EBITDA | 26,852 | ' | ' | 25,307 | 72,568 | 72,758 | ' |
Advanced Surgical [Member] | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Revenue | 53,169 | ' | ' | 48,996 | 148,827 | 147,170 | ' |
Adjusted EBITDA | 9,493 | ' | ' | 8,470 | 22,638 | 22,586 | ' |
Impairment of goodwill | ' | ' | -16,000 | ' | ' | ' | ' |
Intersegment Elimination [Member] | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Revenue | -1,069 | ' | ' | -2,585 | -2,364 | -6,879 | ' |
Corporate [Member] | ' | ' | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Adjusted EBITDA | ($5,761) | ' | ' | ($5,625) | ($18,569) | ($19,400) | ' |
Segment_Information_Reconcilia
Segment Information - Reconciliation of Capital Expenditures (Details) (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Segment Reporting Information [Line Items] | ' | ' |
Capital expenditures | $16,193 | $13,180 |
Cardio and Vascular [Member] | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Capital expenditures | 8,144 | 6,191 |
Advanced Surgical [Member] | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Capital expenditures | 7,769 | 6,279 |
Corporate [Member] | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Capital expenditures | $280 | $710 |
Segment_Information_Reconcilia1
Segment Information - Reconciliation of Assets (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Segment Reporting Information [Line Items] | ' | ' |
Assets | $996,731 | $1,061,172 |
Cardio and Vascular [Member] | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Assets | 619,541 | 606,304 |
Advanced Surgical [Member] | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Assets | 181,577 | 245,619 |
Corporate [Member] | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Assets | $195,613 | $209,249 |